Strains of Escherichia coli that preferentially grow and persist within the urinary tract. They exhibit certain virulence factors and strategies that cause urinary tract infections.
Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA.
Infections with bacteria of the species ESCHERICHIA COLI.
Thin, filamentous protein structures, including proteinaceous capsular antigens (fimbrial antigens), that mediate adhesion of E. coli to surfaces and play a role in pathogenesis. They have a high affinity for various epithelial cells.
Proteins obtained from ESCHERICHIA COLI.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc.
Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX).
Inflammation of the KIDNEY involving the renal parenchyma (the NEPHRONS); KIDNEY PELVIS; and KIDNEY CALICES. It is characterized by ABDOMINAL PAIN; FEVER; NAUSEA; VOMITING; and occasionally DIARRHEA.
Proteins that are structural components of bacterial fimbriae (FIMBRIAE, BACTERIAL) or sex pili (PILI, SEX).
Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
A musculomembranous sac along the URINARY TRACT. URINE flows from the KIDNEYS into the bladder via the ureters (URETER), and is held there until URINATION.
Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity.
The duct which coveys URINE from the pelvis of the KIDNEY through the URETERS, BLADDER, and URETHRA.
The epithelial lining of the URINARY TRACT.
Those components of an organism that determine its capacity to cause disease but are not required for its viability per se. Two classes have been characterized: TOXINS, BIOLOGICAL and surface adhesion molecules that effect the ability of the microorganism to invade and colonize a host. (From Davis et al., Microbiology, 4th ed. p486)
The functional hereditary units of BACTERIA.
The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
Proteins found in any species of bacterium.
Any of the processes by which cytoplasmic or intercellular factors influence the differential control of gene action in bacteria.
The aggregation of ERYTHROCYTES by AGGLUTININS, including antibodies, lectins, and viral proteins (HEMAGGLUTINATION, VIRAL).
Deoxyribonucleic acid that makes up the genetic material of bacteria.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
A species of gram-negative, rod-shaped bacteria belonging to the K serogroup of ESCHERICHIA COLI. It lives as a harmless inhabitant of the human LARGE INTESTINE and is widely used in medical and GENETIC RESEARCH.
Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.
A tetraspanin domain-containing uroplakin subtype. It heterodimerizes with UROPLAKIN II to form a component of the asymmetric unit membrane found in urothelial cells.
In bacteria, a group of metabolically related genes, with a common promoter, whose transcription into a single polycistronic MESSENGER RNA is under the control of an OPERATOR REGION.
Glycosphingolipids containing N-acetylglucosamine (paragloboside) or N-acetylgalactosamine (globoside). Globoside is the P antigen on erythrocytes and paragloboside is an intermediate in the biosynthesis of erythrocyte blood group ABH and P 1 glycosphingolipid antigens. The accumulation of globoside in tissue, due to a defect in hexosaminidases A and B, is the cause of Sandhoff disease.
A plant species of the family VACCINIUM known for the sour fruit which is sometimes used for urinary tract infections.
Proteins isolated from the outer membrane of Gram-negative bacteria.
Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS.
A verocytotoxin-producing serogroup belonging to the O subfamily of Escherichia coli which has been shown to cause severe food-borne disease. A strain from this serogroup, serotype H7, which produces SHIGA TOXINS, has been linked to human disease outbreaks resulting from contamination of foods by E. coli O157 from bovine origin.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Cell-surface components or appendages of bacteria that facilitate adhesion (BACTERIAL ADHESION) to other cells or to inanimate surfaces. Most fimbriae (FIMBRIAE, BACTERIAL) of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin. In gram-positive bacteria, a protein or polysaccharide surface layer serves as the specific adhesin. What is sometimes called polymeric adhesin (BIOFILMS) is distinct from protein adhesin.
The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION.
Encrustations, formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedding in extracellular polymers, that adhere to surfaces such as teeth (DENTAL DEPOSITS); PROSTHESES AND IMPLANTS; and catheters. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and antifouling agents.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
Inbred CBA mice are a strain of laboratory mice that have been selectively bred to be genetically identical and uniform, which makes them useful for scientific research, particularly in the areas of immunology and cancer.
A large superfamily of cell surface membrane proteins characterized by their four transmembrane domains. They play a role in a variety of processes such as cellular adhesion and motility. They may be involved in the organization of cell surface MEMBRANE MICRODOMAINS that regulate the activation of LEUKOCYTES.
Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS.
Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS.
The biological objects that contain genetic information and that are involved in transmitting genetically encoded traits from one organism to another.
Proteins found in the PERIPLASM of organisms with cell walls.
Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.
Distinct units in some bacterial, bacteriophage or plasmid GENOMES that are types of MOBILE GENETIC ELEMENTS. Encoded in them are a variety of fitness conferring genes, such as VIRULENCE FACTORS (in "pathogenicity islands or islets"), ANTIBIOTIC RESISTANCE genes, or genes required for SYMBIOSIS (in "symbiosis islands or islets"). They range in size from 10 - 500 kilobases, and their GC CONTENT and CODON usage differ from the rest of the genome. They typically contain an INTEGRASE gene, although in some cases this gene has been deleted resulting in "anchored genomic islands".
Inbred C3H mice are a strain of laboratory mice that have been selectively bred to maintain a high degree of genetic uniformity and share specific genetic characteristics, including susceptibility to certain diseases, which makes them valuable for biomedical research purposes.
The presence of bacteria in the urine which is normally bacteria-free. These bacteria are from the URINARY TRACT and are not contaminants of the surrounding tissues. Bacteriuria can be symptomatic or asymptomatic. Significant bacteriuria is an indicator of urinary tract infection.
A blood group related to the ABO, Lewis and I systems. At least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group.
Substances that reduce the growth or reproduction of BACTERIA.
Agents that cause agglutination of red blood cells. They include antibodies, blood group antigens, lectins, autoimmune factors, bacterial, viral, or parasitic blood agglutinins, etc.
The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash Fraxinus ornus and related plants. (From Grant & Hackh's Chemical Dictionary, 5th ed & Random House Unabridged Dictionary, 2d ed)
Sets of cell surface antigens located on BLOOD CELLS. They are usually membrane GLYCOPROTEINS or GLYCOLIPIDS that are antigenically distinguished by their carbohydrate moieties.
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading.
Pathological processes of the female URINARY TRACT and the reproductive system (GENITALIA, FEMALE).
A test used to determine whether or not complementation (compensation in the form of dominance) will occur in a cell with a given mutant phenotype when another mutant genome, encoding the same mutant phenotype, is introduced into that cell.
This drug combination has proved to be an effective therapeutic agent with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (The Encyclopedia of Molecular Biology, 1994)
A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus.
A whiplike motility appendage present on the surface cells. Prokaryote flagella are composed of a protein called FLAGELLIN. Bacteria can have a single flagellum, a tuft at one pole, or multiple flagella covering the entire surface. In eukaryotes, flagella are threadlike protoplasmic extensions used to propel flagellates and sperm. Flagella have the same basic structure as CILIA but are longer in proportion to the cell bearing them and present in much smaller numbers. (From King & Stansfield, A Dictionary of Genetics, 4th ed)
Pathological processes of the URINARY BLADDER.
A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
Substances elaborated by bacteria that have antigenic activity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
Structures within the nucleus of bacterial cells consisting of or containing DNA, which carry genetic information essential to the cell.
Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed)
The genetic complement of a BACTERIA as represented in its DNA.
The relationships of groups of organisms as reflected by their genetic makeup.
Tests that are dependent on the clumping of cells, microorganisms, or particles when mixed with specific antiserum. (From Stedman, 26th ed)
The rate dynamics in chemical or physical systems.
Discrete segments of DNA which can excise and reintegrate to another site in the genome. Most are inactive, i.e., have not been found to exist outside the integrated state. DNA transposable elements include bacterial IS (insertion sequence) elements, Tn elements, the maize controlling elements Ac and Ds, Drosophila P, gypsy, and pogo elements, the human Tigger elements and the Tc and mariner elements which are found throughout the animal kingdom.
Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping.
Ribonucleic acid in bacteria having regulatory and catalytic roles as well as involvement in protein synthesis.
Proteins prepared by recombinant DNA technology.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A family of cellular proteins that mediate the correct assembly or disassembly of polypeptides and their associated ligands. Although they take part in the assembly process, molecular chaperones are not components of the final structures.
The arrangement of two or more amino acid or base sequences from an organism or organisms in such a way as to align areas of the sequences sharing common properties. The degree of relatedness or homology between the sequences is predicted computationally or statistically based on weights assigned to the elements aligned between the sequences. This in turn can serve as a potential indicator of the genetic relatedness between the organisms.
Any compound containing one or more monosaccharide residues bound by a glycosidic linkage to a hydrophobic moiety such as an acylglycerol (see GLYCERIDES), a sphingoid, a ceramide (CERAMIDES) (N-acylsphingoid) or a prenyl phosphate. (From IUPAC's webpage)
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
Viruses whose host is Escherichia coli.
Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors.
The interactions between a host and a pathogen, usually resulting in disease.
Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503)
Gel electrophoresis in which the direction of the electric field is changed periodically. This technique is similar to other electrophoretic methods normally used to separate double-stranded DNA molecules ranging in size up to tens of thousands of base-pairs. However, by alternating the electric field direction one is able to separate DNA molecules up to several million base-pairs in length.
Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA.
The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms.
Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage)
The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
A broad-spectrum antimicrobial carboxyfluoroquinoline.
The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species.
Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases.
Microscopy using an electron beam, instead of light, to visualize the sample, thereby allowing much greater magnification. The interactions of ELECTRONS with specimens are used to provide information about the fine structure of that specimen. In TRANSMISSION ELECTRON MICROSCOPY the reactions of the electrons that are transmitted through the specimen are imaged. In SCANNING ELECTRON MICROSCOPY an electron beam falls at a non-normal angle on the specimen and the image is derived from the reactions occurring above the plane of the specimen.
Strains of ESCHERICHIA COLI that produce or contain at least one member of either heat-labile or heat-stable ENTEROTOXINS. The organisms colonize the mucosal surface of the small intestine and elaborate their enterotoxins causing DIARRHEA. They are mainly associated with tropical and developing countries and affect susceptible travelers to those places.
Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes.
Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands.
A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN.
The level of protein structure in which combinations of secondary protein structures (alpha helices, beta sheets, loop regions, and motifs) pack together to form folded shapes called domains. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Small proteins usually consist of only one domain but larger proteins may contain a number of domains connected by segments of polypeptide chain which lack regular secondary structure.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
Strains of ESCHERICHIA COLI with the ability to produce at least one or more of at least two antigenically distinct, usually bacteriophage-mediated cytotoxins: SHIGA TOXIN 1 and SHIGA TOXIN 2. These bacteria can cause severe disease in humans including bloody DIARRHEA and HEMOLYTIC UREMIC SYNDROME.
Vaccines or candidate vaccines used to prevent or treat both enterotoxigenic and enteropathogenic Escherichia coli infections.
Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN.
The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms.
Strains of ESCHERICHIA COLI characterized by attaching-and-effacing histopathology. These strains of bacteria intimately adhere to the epithelial cell membrane and show effacement of microvilli. In developed countries they are associated with INFANTILE DIARRHEA and infantile GASTROENTERITIS and, in contrast to ETEC strains, do not produce ENDOTOXINS.
The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS.
The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS.
Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
A parasexual process in BACTERIA; ALGAE; FUNGI; and ciliate EUKARYOTA for achieving exchange of chromosome material during fusion of two cells. In bacteria, this is a uni-directional transfer of genetic material; in protozoa it is a bi-directional exchange. In algae and fungi, it is a form of sexual reproduction, with the union of male and female gametes.
Any method used for determining the location of and relative distances between genes on a chromosome.
Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment.
Electrophoresis in which a polyacrylamide gel is used as the diffusion medium.
Established cell cultures that have the potential to propagate indefinitely.
A species of gram-negative, facultatively anaerobic, rod-shaped bacteria that is frequently isolated from clinical specimens. Its most common site of infection is the urinary tract.
A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria whose organisms occur in the lower part of the intestine of warm-blooded animals. The species are either nonpathogenic or opportunistic pathogens.
One or more layers of EPITHELIAL CELLS, supported by the basal lamina, which covers the inner or outer surfaces of the body.
The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain).
Strains of ESCHERICHIA COLI that are a subgroup of SHIGA-TOXIGENIC ESCHERICHIA COLI. They cause non-bloody and bloody DIARRHEA; HEMOLYTIC UREMIC SYNDROME; and hemorrhagic COLITIS. An important member of this subgroup is ESCHERICHIA COLI O157-H7.
Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.
The sum of the weight of all the atoms in a molecule.
Transport proteins that carry specific substances in the blood or across cell membranes.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1.

Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household. (1/169)

 (+info)

High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City. (2/169)

BACKGROUND: The prevalence of antimicrobial resistance among uropathogenic E. coli varies widely worldwide; to guide empirical therapy is necessary to have local, up-to-date susceptibility data. METHODOLOGY: We tested 907 isolates from patients in Mexico City by disk diffusion and further characterized ciprofloxacin, cephalosporin and nitrofurantoin resistant strains. RESULTS: Isolates were mostly resistant to ampicillin (74%), trimethoprim-sulfamethoxazole (60.1%) and ciprofloxacin (32.6%). The most effective drug was netilmicin (5.1% resistant) and the most effective of oral drugs was nitrofurantoin (7.4% resistant). Sixty-percent of ciprofloxacin-resistant strains had minimal inhibitory concentrations of 125 microg/ml or higher, well beyond urinary concentrations at the end of the 12-hour inter-dose period for standard oral regimes. Extended-spectrum beta-lactamases were detected in 6% of strains, most of them from community-acquired infections. All strains resistant to nitrofurantoin carried a 20 Kb plasmid, which when transformed into a susceptible recipient, conferred resistance to nitrofurantoin, ampicillin, sulfonamides, streptomycin, and partially protected against ciprofloxacin. CONCLUSIONS: Drugs considered of choice against uncomplicated urinary tract infections are facing high resistance prevalences and resistance determinants formerly seen only at hospitals are now among community strains. Treatment guidelines from developed countries might not reflect these local trends.  (+info)

Absence of ZnuABC-mediated zinc uptake affects virulence-associated phenotypes of uropathogenic Escherichia coli CFT073 under Zn(II)-depleted conditions. (3/169)

 (+info)

Uropathogenic Escherichia coli Suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. (4/169)

 (+info)

OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis. (5/169)

 (+info)

Difference in the regulation of IL-8 expression induced by uropathogenic E. coli between two kinds of urinary tract epithelial cells. (6/169)

 (+info)

Identification of uropathogenic Escherichia coli clonal group A (CgA) in hospitalised patients. (7/169)

 (+info)

(CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR. (8/169)

 (+info)

Uropathogenic Escherichia coli (UPEC) are a subgroup of E. coli bacteria that have developed the ability to cause urinary tract infections (UTIs). These infections can affect any part of the urinary system, including the kidneys, ureters, bladder, and urethra. UPEC are responsible for the majority of uncomplicated UTIs in otherwise healthy individuals.

UPEC possess various virulence factors that allow them to adhere to and colonize the urinary tract, evade host immune responses, and cause tissue damage. Some of these virulence factors include fimbriae, which are hair-like structures that help the bacteria attach to host cells; toxins such as hemolysin, which can damage host cells; and polysaccharide capsules, which protect the bacteria from phagocytosis by host immune cells.

UPEC can cause a range of UTI symptoms, including frequent urination, pain or burning during urination, strong-smelling or cloudy urine, and fever. If left untreated, UTIs caused by UPEC can lead to more serious complications, such as kidney damage or bloodstream infections. Treatment typically involves antibiotics that are effective against UPEC, such as trimethoprim-sulfamethoxazole, nitrofurantoin, or fluoroquinolones. However, the increasing prevalence of antibiotic resistance among UPEC isolates is a growing concern and highlights the need for ongoing research into new treatment strategies.

Urinary Tract Infections (UTIs) are defined as the presence of pathogenic microorganisms, typically bacteria, in any part of the urinary system, which includes the kidneys, ureters, bladder, and urethra, resulting in infection and inflammation. The majority of UTIs are caused by Escherichia coli (E. coli) bacteria, but other organisms such as Klebsiella, Proteus, Staphylococcus saprophyticus, and Enterococcus can also cause UTIs.

UTIs can be classified into two types based on the location of the infection:

1. Lower UTI or bladder infection (cystitis): This type of UTI affects the bladder and urethra. Symptoms may include a frequent and urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back.

2. Upper UTI or kidney infection (pyelonephritis): This type of UTI affects the kidneys and can be more severe than a bladder infection. Symptoms may include fever, chills, nausea, vomiting, and pain in the flanks or back.

UTIs are more common in women than men due to their shorter urethra, which makes it easier for bacteria to reach the bladder. Other risk factors for UTIs include sexual activity, use of diaphragms or spermicides, urinary catheterization, diabetes, and weakened immune systems.

UTIs are typically diagnosed through a urinalysis and urine culture to identify the causative organism and determine the appropriate antibiotic treatment. In some cases, imaging studies such as ultrasound or CT scan may be necessary to evaluate for any underlying abnormalities in the urinary tract.

Escherichia coli (E. coli) infections refer to illnesses caused by the bacterium E. coli, which can cause a range of symptoms depending on the specific strain and site of infection. The majority of E. coli strains are harmless and live in the intestines of healthy humans and animals. However, some strains, particularly those that produce Shiga toxins, can cause severe illness.

E. coli infections can occur through various routes, including contaminated food or water, person-to-person contact, or direct contact with animals or their environments. Common symptoms of E. coli infections include diarrhea (often bloody), abdominal cramps, nausea, and vomiting. In severe cases, complications such as hemolytic uremic syndrome (HUS) can occur, which may lead to kidney failure and other long-term health problems.

Preventing E. coli infections involves practicing good hygiene, cooking meats thoroughly, avoiding cross-contamination of food during preparation, washing fruits and vegetables before eating, and avoiding unpasteurized dairy products and juices. Prompt medical attention is necessary if symptoms of an E. coli infection are suspected to prevent potential complications.

Adhesins in Escherichia coli (E. coli) refer to proteins or structures on the surface of E. coli bacteria that allow them to adhere to host cells or surfaces. These adhesins play a crucial role in the initial attachment and colonization of the bacterium to the host, which can lead to infection and disease.

There are several types of adhesins found in E. coli, including fimbrial and non-fimbrial adhesins. Fimbrial adhesins, also known as pili, are hair-like structures that extend from the surface of the bacterium and can bind to specific receptors on host cells. Non-fimbrial adhesins, on the other hand, are proteins located on the outer membrane of the bacterium that can mediate adherence to host cells or surfaces.

One well-known example of an E. coli adhesin is the P fimbriae, which is associated with urinary tract infections (UTIs). The P fimbriae bind to galabiose receptors on the surface of uroepithelial cells, allowing the bacterium to colonize and infect the urinary tract. Other types of E. coli adhesins have been implicated in various extraintestinal infections, such as meningitis, sepsis, and neonatal meningitis.

Understanding the mechanisms of E. coli adhesion is important for developing strategies to prevent and treat infections caused by this bacterium.

'Escherichia coli (E. coli) proteins' refer to the various types of proteins that are produced and expressed by the bacterium Escherichia coli. These proteins play a critical role in the growth, development, and survival of the organism. They are involved in various cellular processes such as metabolism, DNA replication, transcription, translation, repair, and regulation.

E. coli is a gram-negative, facultative anaerobe that is commonly found in the intestines of warm-blooded organisms. It is widely used as a model organism in scientific research due to its well-studied genetics, rapid growth, and ability to be easily manipulated in the laboratory. As a result, many E. coli proteins have been identified, characterized, and studied in great detail.

Some examples of E. coli proteins include enzymes involved in carbohydrate metabolism such as lactase, sucrase, and maltose; proteins involved in DNA replication such as the polymerases, single-stranded binding proteins, and helicases; proteins involved in transcription such as RNA polymerase and sigma factors; proteins involved in translation such as ribosomal proteins, tRNAs, and aminoacyl-tRNA synthetases; and regulatory proteins such as global regulators, two-component systems, and transcription factors.

Understanding the structure, function, and regulation of E. coli proteins is essential for understanding the basic biology of this important organism, as well as for developing new strategies for combating bacterial infections and improving industrial processes involving bacteria.

'Escherichia coli' (E. coli) is a type of gram-negative, facultatively anaerobic, rod-shaped bacterium that commonly inhabits the intestinal tract of humans and warm-blooded animals. It is a member of the family Enterobacteriaceae and one of the most well-studied prokaryotic model organisms in molecular biology.

While most E. coli strains are harmless and even beneficial to their hosts, some serotypes can cause various forms of gastrointestinal and extraintestinal illnesses in humans and animals. These pathogenic strains possess virulence factors that enable them to colonize and damage host tissues, leading to diseases such as diarrhea, urinary tract infections, pneumonia, and sepsis.

E. coli is a versatile organism with remarkable genetic diversity, which allows it to adapt to various environmental niches. It can be found in water, soil, food, and various man-made environments, making it an essential indicator of fecal contamination and a common cause of foodborne illnesses. The study of E. coli has contributed significantly to our understanding of fundamental biological processes, including DNA replication, gene regulation, and protein synthesis.

Bacterial fimbriae are thin, hair-like protein appendages that extend from the surface of many types of bacteria. They are involved in the attachment of bacteria to surfaces, other cells, or extracellular structures. Fimbriae enable bacteria to adhere to host tissues and form biofilms, which contribute to bacterial pathogenicity and survival in various environments. These protein structures are composed of several thousand subunits of a specific protein called pilin. Some fimbriae can recognize and bind to specific receptors on host cells, initiating the process of infection and colonization.

Pyelonephritis is a type of urinary tract infection (UTI) that involves the renal pelvis and the kidney parenchyma. It's typically caused by bacterial invasion, often via the ascending route from the lower urinary tract. The most common causative agent is Escherichia coli (E. coli), but other bacteria such as Klebsiella, Proteus, and Pseudomonas can also be responsible.

Acute pyelonephritis can lead to symptoms like fever, chills, flank pain, nausea, vomiting, and frequent or painful urination. If left untreated, it can potentially cause permanent kidney damage, sepsis, or other complications. Chronic pyelonephritis, on the other hand, is usually associated with underlying structural or functional abnormalities of the urinary tract.

Diagnosis typically involves a combination of clinical evaluation, urinalysis, and imaging studies, while treatment often consists of antibiotics tailored to the identified pathogen and the patient's overall health status.

Fimbriae proteins are specialized protein structures found on the surface of certain bacteria, including some pathogenic species. Fimbriae, also known as pili, are thin, hair-like appendages that extend from the bacterial cell wall and play a role in the attachment of the bacterium to host cells or surfaces.

Fimbrial proteins are responsible for the assembly and structure of these fimbriae. They are produced by the bacterial cell and then self-assemble into long, thin fibers that extend from the surface of the bacterium. The proteins have a highly conserved sequence at their carboxy-terminal end, which is important for their polymerization and assembly into fimbriae.

Fimbrial proteins can vary widely between different species of bacteria, and even between strains of the same species. Some fimbrial proteins are adhesins, meaning they bind to specific receptors on host cells, allowing the bacterium to attach to and colonize tissues. Other fimbrial proteins may play a role in biofilm formation or other aspects of bacterial pathogenesis.

Understanding the structure and function of fimbrial proteins is important for developing new strategies to prevent or treat bacterial infections, as these proteins can be potential targets for vaccines or therapeutic agents.

Cystitis is a medical term that refers to inflammation of the bladder, usually caused by a bacterial infection. The infection can occur when bacteria from the digestive tract or skin enter the urinary tract through the urethra and travel up to the bladder. This condition is more common in women than men due to their shorter urethras, which makes it easier for bacteria to reach the bladder.

Symptoms of cystitis may include a strong, frequent, or urgent need to urinate, pain or burning during urination, cloudy or strong-smelling urine, and discomfort in the lower abdomen or back. In some cases, there may be blood in the urine, fever, chills, or nausea and vomiting.

Cystitis can usually be treated with antibiotics to kill the bacteria causing the infection. Drinking plenty of water to flush out the bacteria and alleviating symptoms with over-the-counter pain medications may also help. Preventive measures include practicing good hygiene, wiping from front to back after using the toilet, urinating after sexual activity, and avoiding using douches or perfumes in the genital area.

The urinary bladder is a muscular, hollow organ in the pelvis that stores urine before it is released from the body. It expands as it fills with urine and contracts when emptying. The typical adult bladder can hold between 400 to 600 milliliters of urine for about 2-5 hours before the urge to urinate occurs. The wall of the bladder contains several layers, including a mucous membrane, a layer of smooth muscle (detrusor muscle), and an outer fibrous adventitia. The muscles of the bladder neck and urethra remain contracted to prevent leakage of urine during filling, and they relax during voiding to allow the urine to flow out through the urethra.

Bacterial adhesion is the initial and crucial step in the process of bacterial colonization, where bacteria attach themselves to a surface or tissue. This process involves specific interactions between bacterial adhesins (proteins, fimbriae, or pili) and host receptors (glycoproteins, glycolipids, or extracellular matrix components). The attachment can be either reversible or irreversible, depending on the strength of interaction. Bacterial adhesion is a significant factor in initiating biofilm formation, which can lead to various infectious diseases and medical device-associated infections.

The urinary tract is a system in the body responsible for producing, storing, and eliminating urine. It includes two kidneys, two ureters, the bladder, and the urethra. The kidneys filter waste and excess fluids from the blood to produce urine, which then travels down the ureters into the bladder. When the bladder is full, urine is released through the urethra during urination. Any part of this system can become infected or inflamed, leading to conditions such as urinary tract infections (UTIs) or kidney stones.

Urothelium is the specialized type of epithelial tissue that lines the urinary tract, including the renal pelvis, ureters, bladder, and urethra. It is a type of transitional epithelium that can change its shape and size depending on the degree of distension or stretching of the organs it lines.

The main function of urothelium is to provide a barrier against urine, which contains various waste products and potential irritants, while also allowing the exchange of ions and water. The urothelial cells are joined together by tight junctions that prevent the passage of substances through the paracellular space, and they also have the ability to transport ions and water through their cell membranes.

In addition to its barrier function, urothelium is also involved in sensory and immune functions. It contains specialized nerve endings that can detect mechanical and chemical stimuli, such as stretch or irritation, and it expresses various antimicrobial peptides and other defense mechanisms that help protect the urinary tract from infection.

Overall, urothelium plays a critical role in maintaining the health and function of the urinary tract, and its dysfunction has been implicated in various urinary tract disorders, such as interstitial cystitis/bladder pain syndrome and bladder cancer.

Virulence factors are characteristics or components of a microorganism, such as bacteria, viruses, fungi, or parasites, that contribute to its ability to cause damage or disease in a host organism. These factors can include various structures, enzymes, or toxins that allow the pathogen to evade the host's immune system, attach to and invade host tissues, obtain nutrients from the host, or damage host cells directly.

Examples of virulence factors in bacteria include:

1. Endotoxins: lipopolysaccharides found in the outer membrane of Gram-negative bacteria that can trigger a strong immune response and inflammation.
2. Exotoxins: proteins secreted by some bacteria that have toxic effects on host cells, such as botulinum toxin produced by Clostridium botulinum or diphtheria toxin produced by Corynebacterium diphtheriae.
3. Adhesins: structures that help the bacterium attach to host tissues, such as fimbriae or pili in Escherichia coli.
4. Capsules: thick layers of polysaccharides or proteins that surround some bacteria and protect them from the host's immune system, like those found in Streptococcus pneumoniae or Klebsiella pneumoniae.
5. Invasins: proteins that enable bacteria to invade and enter host cells, such as internalins in Listeria monocytogenes.
6. Enzymes: proteins that help bacteria obtain nutrients from the host by breaking down various molecules, like hemolysins that lyse red blood cells to release iron or hyaluronidases that degrade connective tissue.

Understanding virulence factors is crucial for developing effective strategies to prevent and treat infectious diseases caused by these microorganisms.

A bacterial gene is a segment of DNA (or RNA in some viruses) that contains the genetic information necessary for the synthesis of a functional bacterial protein or RNA molecule. These genes are responsible for encoding various characteristics and functions of bacteria such as metabolism, reproduction, and resistance to antibiotics. They can be transmitted between bacteria through horizontal gene transfer mechanisms like conjugation, transformation, and transduction. Bacterial genes are often organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule.

It's important to note that the term "bacterial gene" is used to describe genetic elements found in bacteria, but not all genetic elements in bacteria are considered genes. For example, some DNA sequences may not encode functional products and are therefore not considered genes. Additionally, some bacterial genes may be plasmid-borne or phage-borne, rather than being located on the bacterial chromosome.

Virulence, in the context of medicine and microbiology, refers to the degree or severity of damage or harm that a pathogen (like a bacterium, virus, fungus, or parasite) can cause to its host. It is often associated with the ability of the pathogen to invade and damage host tissues, evade or suppress the host's immune response, replicate within the host, and spread between hosts.

Virulence factors are the specific components or mechanisms that contribute to a pathogen's virulence, such as toxins, enzymes, adhesins, and capsules. These factors enable the pathogen to establish an infection, cause tissue damage, and facilitate its transmission between hosts. The overall virulence of a pathogen can be influenced by various factors, including host susceptibility, environmental conditions, and the specific strain or species of the pathogen.

Bacterial proteins are a type of protein that are produced by bacteria as part of their structural or functional components. These proteins can be involved in various cellular processes, such as metabolism, DNA replication, transcription, and translation. They can also play a role in bacterial pathogenesis, helping the bacteria to evade the host's immune system, acquire nutrients, and multiply within the host.

Bacterial proteins can be classified into different categories based on their function, such as:

1. Enzymes: Proteins that catalyze chemical reactions in the bacterial cell.
2. Structural proteins: Proteins that provide structural support and maintain the shape of the bacterial cell.
3. Signaling proteins: Proteins that help bacteria to communicate with each other and coordinate their behavior.
4. Transport proteins: Proteins that facilitate the movement of molecules across the bacterial cell membrane.
5. Toxins: Proteins that are produced by pathogenic bacteria to damage host cells and promote infection.
6. Surface proteins: Proteins that are located on the surface of the bacterial cell and interact with the environment or host cells.

Understanding the structure and function of bacterial proteins is important for developing new antibiotics, vaccines, and other therapeutic strategies to combat bacterial infections.

Gene expression regulation in bacteria refers to the complex cellular processes that control the production of proteins from specific genes. This regulation allows bacteria to adapt to changing environmental conditions and ensure the appropriate amount of protein is produced at the right time.

Bacteria have a variety of mechanisms for regulating gene expression, including:

1. Operon structure: Many bacterial genes are organized into operons, which are clusters of genes that are transcribed together as a single mRNA molecule. The expression of these genes can be coordinately regulated by controlling the transcription of the entire operon.
2. Promoter regulation: Transcription is initiated at promoter regions upstream of the gene or operon. Bacteria have regulatory proteins called sigma factors that bind to the promoter and recruit RNA polymerase, the enzyme responsible for transcribing DNA into RNA. The binding of sigma factors can be influenced by environmental signals, allowing for regulation of transcription.
3. Attenuation: Some operons have regulatory regions called attenuators that control transcription termination. These regions contain hairpin structures that can form in the mRNA and cause transcription to stop prematurely. The formation of these hairpins is influenced by the concentration of specific metabolites, allowing for regulation of gene expression based on the availability of those metabolites.
4. Riboswitches: Some bacterial mRNAs contain regulatory elements called riboswitches that bind small molecules directly. When a small molecule binds to the riboswitch, it changes conformation and affects transcription or translation of the associated gene.
5. CRISPR-Cas systems: Bacteria use CRISPR-Cas systems for adaptive immunity against viruses and plasmids. These systems incorporate short sequences from foreign DNA into their own genome, which can then be used to recognize and cleave similar sequences in invading genetic elements.

Overall, gene expression regulation in bacteria is a complex process that allows them to respond quickly and efficiently to changing environmental conditions. Understanding these regulatory mechanisms can provide insights into bacterial physiology and help inform strategies for controlling bacterial growth and behavior.

Hemagglutination is a medical term that refers to the agglutination or clumping together of red blood cells (RBCs) in the presence of an agglutinin, which is typically a protein or a polysaccharide found on the surface of certain viruses, bacteria, or incompatible blood types.

In simpler terms, hemagglutination occurs when the agglutinin binds to specific antigens on the surface of RBCs, causing them to clump together and form visible clumps or aggregates. This reaction is often used in diagnostic tests to identify the presence of certain viruses or bacteria, such as influenza or HIV, by mixing a sample of blood or other bodily fluid with a known agglutinin and observing whether hemagglutination occurs.

Hemagglutination inhibition (HI) assays are also commonly used to measure the titer or concentration of antibodies in a serum sample, by adding serial dilutions of the serum to a fixed amount of agglutinin and observing the highest dilution that still prevents hemagglutination. This can help determine whether a person has been previously exposed to a particular pathogen and has developed immunity to it.

Bacterial DNA refers to the genetic material found in bacteria. It is composed of a double-stranded helix containing four nucleotide bases - adenine (A), thymine (T), guanine (G), and cytosine (C) - that are linked together by phosphodiester bonds. The sequence of these bases in the DNA molecule carries the genetic information necessary for the growth, development, and reproduction of bacteria.

Bacterial DNA is circular in most bacterial species, although some have linear chromosomes. In addition to the main chromosome, many bacteria also contain small circular pieces of DNA called plasmids that can carry additional genes and provide resistance to antibiotics or other environmental stressors.

Unlike eukaryotic cells, which have their DNA enclosed within a nucleus, bacterial DNA is present in the cytoplasm of the cell, where it is in direct contact with the cell's metabolic machinery. This allows for rapid gene expression and regulation in response to changing environmental conditions.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Escherichia coli (E. coli) K12 is a strain of the bacterium E. coli that is commonly used in scientific research. It was originally isolated from the human intestine and has been well-studied due to its relatively harmless nature compared to other strains of E. coli that can cause serious illness.

The "K12" designation refers to a specific set of genetic characteristics that distinguish this strain from others. It is a non-pathogenic, or non-harmful, strain that is often used as a model organism in molecular biology and genetics research. Researchers have developed many tools and resources for studying E. coli K12, including a complete genome sequence and extensive collections of mutant strains.

E. coli K12 is not typically found in the environment and is not associated with disease in healthy individuals. However, it can be used as an indicator organism to detect fecal contamination in water supplies, since it is commonly present in the intestines of warm-blooded animals.

Urine is a physiological excretory product that is primarily composed of water, urea, and various ions (such as sodium, potassium, chloride, and others) that are the byproducts of protein metabolism. It also contains small amounts of other substances like uric acid, creatinine, ammonia, and various organic compounds. Urine is produced by the kidneys through a process called urination or micturition, where it is filtered from the blood and then stored in the bladder until it is excreted from the body through the urethra. The color, volume, and composition of urine can provide important diagnostic information about various medical conditions.

Uroplakin Ia is not a medical term itself, but it is a component of uroplakins which are a group of proteins found in the urothelium, the tissue that lines the urinary tract. Uroplakins are involved in the formation of the asymmetric unit membrane (AUM) of the urothelial plaques, which are specialized structures on the apical surface of the superficial urothelial cells. These plaques provide a barrier function and protect the underlying tissues from various harmful substances in urine.

Uroplakin Ia is one of the four major uroplakins (UPIa, UPIb, UPII, and UPIII) that form heterodimers and then assemble into larger complexes to form the urothelial plaques. Specifically, Uroplakin Ia combines with Uroplakin Ib to form a heterodimer, which then associates with UPII and UPIII heterodimers to form a tetraspanin complex. These complexes are then incorporated into the AUM of the urothelial plaques.

Abnormalities in uroplakins have been associated with various urological disorders, including bladder cancer, interstitial cystitis, and chronic pelvic pain syndrome.

An operon is a genetic unit in prokaryotic organisms (like bacteria) consisting of a cluster of genes that are transcribed together as a single mRNA molecule, which then undergoes translation to produce multiple proteins. This genetic organization allows for the coordinated regulation of genes that are involved in the same metabolic pathway or functional process. The unit typically includes promoter and operator regions that control the transcription of the operon, as well as structural genes encoding the proteins. Operons were first discovered in bacteria, but similar genetic organizations have been found in some eukaryotic organisms, such as yeast.

Globosides are a type of glycosphingolipids, which are molecules that consist of a lipid and a carbohydrate. They are found in animal tissues, especially in the nervous system. The term "globoside" refers to a specific structure of these molecules, where the carbohydrate portion consists of a complex chain of sugars, including galactose, N-acetylgalactosamine, and glucose. Globosides play important roles in cell recognition and interaction, and abnormalities in their metabolism have been associated with certain diseases, such as paroxysmal nocturnal hemoglobinuria (PNH).

"Vaccinium macrocarpon" is the scientific name for the American cranberry, a type of evergreen shrub that produces berries which are commonly used in food and also have potential health benefits. The active ingredients in cranberries, including proanthocyanidins, are thought to help prevent urinary tract infections by preventing bacteria from adhering to the walls of the urinary tract. However, it is important to note that consuming cranberry products should not be considered a substitute for medical treatment for UTIs or any other health conditions.

Bacterial outer membrane proteins (OMPs) are a type of protein found in the outer membrane of gram-negative bacteria. The outer membrane is a unique characteristic of gram-negative bacteria, and it serves as a barrier that helps protect the bacterium from hostile environments. OMPs play a crucial role in maintaining the structural integrity and selective permeability of the outer membrane. They are involved in various functions such as nutrient uptake, transport, adhesion, and virulence factor secretion.

OMPs are typically composed of beta-barrel structures that span the bacterial outer membrane. These proteins can be classified into several groups based on their size, function, and structure. Some of the well-known OMP families include porins, autotransporters, and two-partner secretion systems.

Porins are the most abundant type of OMPs and form water-filled channels that allow the passive diffusion of small molecules, ions, and nutrients across the outer membrane. Autotransporters are a diverse group of OMPs that play a role in bacterial pathogenesis by secreting virulence factors or acting as adhesins. Two-partner secretion systems involve the cooperation between two proteins to transport effector molecules across the outer membrane.

Understanding the structure and function of bacterial OMPs is essential for developing new antibiotics and therapies that target gram-negative bacteria, which are often resistant to conventional treatments.

A plasmid is a small, circular, double-stranded DNA molecule that is separate from the chromosomal DNA of a bacterium or other organism. Plasmids are typically not essential for the survival of the organism, but they can confer beneficial traits such as antibiotic resistance or the ability to degrade certain types of pollutants.

Plasmids are capable of replicating independently of the chromosomal DNA and can be transferred between bacteria through a process called conjugation. They often contain genes that provide resistance to antibiotics, heavy metals, and other environmental stressors. Plasmids have also been engineered for use in molecular biology as cloning vectors, allowing scientists to replicate and manipulate specific DNA sequences.

Plasmids are important tools in genetic engineering and biotechnology because they can be easily manipulated and transferred between organisms. They have been used to produce vaccines, diagnostic tests, and genetically modified organisms (GMOs) for various applications, including agriculture, medicine, and industry.

Escherichia coli (E. coli) O157 is a serotype of the bacterium E. coli that is associated with foodborne illness. This strain is pathogenic and produces Shiga toxins, which can cause severe damage to the lining of the small intestine and potentially lead to hemorrhagic diarrhea and kidney failure. E. coli O157 is often transmitted through contaminated food, particularly undercooked ground beef, as well as raw or unpasteurized dairy products, fruits, and vegetables. It can also be spread through contact with infected individuals or animals, especially in settings like farms, petting zoos, and swimming pools. Proper food handling, cooking, and hygiene practices are crucial to preventing E. coli O157 infections.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Bacterial adhesins are proteins or structures on the surface of bacterial cells that allow them to attach to other cells or surfaces. This ability to adhere to host tissues is an important first step in the process of bacterial infection and colonization. Adhesins can recognize and bind to specific receptors on host cells, such as proteins or sugars, enabling the bacteria to establish a close relationship with the host and evade immune responses.

There are several types of bacterial adhesins, including fimbriae, pili, and non-fimbrial adhesins. Fimbriae and pili are thin, hair-like structures that extend from the bacterial surface and can bind to a variety of host cell receptors. Non-fimbrial adhesins are proteins that are directly embedded in the bacterial cell wall and can also mediate attachment to host cells.

Bacterial adhesins play a crucial role in the pathogenesis of many bacterial infections, including urinary tract infections, respiratory tract infections, and gastrointestinal infections. Understanding the mechanisms of bacterial adhesion is important for developing new strategies to prevent and treat bacterial infections.

An amino acid sequence is the specific order of amino acids in a protein or peptide molecule, formed by the linking of the amino group (-NH2) of one amino acid to the carboxyl group (-COOH) of another amino acid through a peptide bond. The sequence is determined by the genetic code and is unique to each type of protein or peptide. It plays a crucial role in determining the three-dimensional structure and function of proteins.

Biofilms are defined as complex communities of microorganisms, such as bacteria and fungi, that adhere to surfaces and are enclosed in a matrix made up of extracellular polymeric substances (EPS). The EPS matrix is composed of polysaccharides, proteins, DNA, and other molecules that provide structural support and protection to the microorganisms within.

Biofilms can form on both living and non-living surfaces, including medical devices, implants, and biological tissues. They are resistant to antibiotics, disinfectants, and host immune responses, making them difficult to eradicate and a significant cause of persistent infections. Biofilms have been implicated in a wide range of medical conditions, including chronic wounds, urinary tract infections, middle ear infections, and device-related infections.

The formation of biofilms typically involves several stages, including initial attachment, microcolony formation, maturation, and dispersion. Understanding the mechanisms underlying biofilm formation and development is crucial for developing effective strategies to prevent and treat biofilm-associated infections.

A mutation is a permanent change in the DNA sequence of an organism's genome. Mutations can occur spontaneously or be caused by environmental factors such as exposure to radiation, chemicals, or viruses. They may have various effects on the organism, ranging from benign to harmful, depending on where they occur and whether they alter the function of essential proteins. In some cases, mutations can increase an individual's susceptibility to certain diseases or disorders, while in others, they may confer a survival advantage. Mutations are the driving force behind evolution, as they introduce new genetic variability into populations, which can then be acted upon by natural selection.

"CBA" is an abbreviation for a specific strain of inbred mice that were developed at the Cancer Research Institute in London. The "Inbred CBA" mice are genetically identical individuals within the same strain, due to many generations of brother-sister matings. This results in a homozygous population, making them valuable tools for research because they reduce variability and increase reproducibility in experimental outcomes.

The CBA strain is known for its susceptibility to certain diseases, such as autoimmune disorders and cancer, which makes it a popular choice for researchers studying those conditions. Additionally, the CBA strain has been widely used in studies related to transplantation immunology, infectious diseases, and genetic research.

It's important to note that while "Inbred CBA" mice are a well-established and useful tool in biomedical research, they represent only one of many inbred strains available for scientific investigation. Each strain has its own unique characteristics and advantages, depending on the specific research question being asked.

Tetraspanins are a family of membrane proteins that are characterized by the presence of four transmembrane domains. They are widely expressed in various tissues and cells, where they play important roles in regulating cell development, activation, motility, and fusion. Tetraspanins can interact with other membrane proteins, such as integrins, receptors, and enzymes, to form complexes that function in signal transduction, trafficking, and adhesion. They also participate in the regulation of various cellular processes, including cell proliferation, differentiation, survival, and apoptosis. Some tetraspanins have been implicated in the pathogenesis of various diseases, such as cancer, autoimmune disorders, and viral infections.

Hemolysins are a type of protein toxin produced by certain bacteria, fungi, and plants that have the ability to damage and destroy red blood cells (erythrocytes), leading to their lysis or hemolysis. This results in the release of hemoglobin into the surrounding environment. Hemolysins can be classified into two main categories:

1. Exotoxins: These are secreted by bacteria and directly damage host cells. They can be further divided into two types:
* Membrane attack complex/perforin-like proteins (MACPF): These hemolysins create pores in the membrane of red blood cells, disrupting their integrity and causing lysis. Examples include alpha-hemolysin from Staphylococcus aureus and streptolysin O from Streptococcus pyogenes.
* Enzymatic hemolysins: These hemolysins are enzymes that degrade specific components of the red blood cell membrane, ultimately leading to lysis. An example is streptolysin S from Streptococcus pyogenes, which is a thiol-activated, oxygen-labile hemolysin.
2. Endotoxins: These are part of the outer membrane of Gram-negative bacteria and can cause indirect hemolysis by activating the complement system or by stimulating the release of inflammatory mediators from host cells.

Hemolysins play a significant role in bacterial pathogenesis, contributing to tissue damage, impaired immune responses, and disease progression.

Cytotoxins are substances that are toxic to cells. They can cause damage and death to cells by disrupting their membranes, interfering with their metabolism, or triggering programmed cell death (apoptosis). Cytotoxins can be produced by various organisms such as bacteria, fungi, plants, and animals, and they can also be synthesized artificially.

In medicine, cytotoxic drugs are used to treat cancer because they selectively target and kill rapidly dividing cells, including cancer cells. Examples of cytotoxic drugs include chemotherapy agents such as doxorubicin, cyclophosphamide, and methotrexate. However, these drugs can also damage normal cells, leading to side effects such as nausea, hair loss, and immune suppression.

It's important to note that cytotoxins are not the same as toxins, which are poisonous substances produced by living organisms that can cause harm to other organisms. While all cytotoxins are toxic to cells, not all toxins are cytotoxic. Some toxins may have systemic effects on organs or tissues rather than directly killing cells.

Genetic structures refer to the organization and composition of genetic material, primarily DNA, that contain the information necessary for the development and function of an organism. This includes the chromosomes, genes, and regulatory elements that make up the genome.

Chromosomes are thread-like structures located in the nucleus of a cell that consist of DNA coiled around histone proteins. They come in pairs, with most species having a specific number of chromosomes in each set (diploid).

Genes are segments of DNA that code for specific proteins or RNA molecules, and they are the basic units of heredity. They can be located on chromosomes and can vary in length and complexity.

Regulatory elements are non-coding sequences of DNA that control the expression of genes by regulating when, where, and to what extent a gene is turned on or off. These elements can include promoters, enhancers, silencers, and insulators.

Overall, genetic structures provide the blueprint for an organism's traits and characteristics, and understanding their organization and function is crucial in fields such as genetics, genomics, and molecular biology.

Periplasmic proteins are a type of protein that are found in the periplasm, which is the compartment between the inner and outer membranes of gram-negative bacteria. This region contains a variety of enzymes and other proteins that play important roles in various cellular processes, including nutrient transport, metabolism, and protection against antibiotics.

Periplasmic proteins are synthesized on the cytoplasmic side of the inner membrane and are then translocated across the membrane into the periplasm through specialized protein channels. Once in the periplasm, these proteins can perform a variety of functions, such as binding to and transporting nutrients, breaking down toxic compounds, or participating in quality control processes that help ensure the proper folding and assembly of other proteins.

Periplasmic proteins are often involved in important bacterial processes, such as the production of antibiotics, the degradation of complex carbohydrates, and the resistance to environmental stresses. As a result, they have attracted interest as potential targets for new antibiotics and other therapeutic agents.

Bacterial toxins are poisonous substances produced and released by bacteria. They can cause damage to the host organism's cells and tissues, leading to illness or disease. Bacterial toxins can be classified into two main types: exotoxins and endotoxins.

Exotoxins are proteins secreted by bacterial cells that can cause harm to the host. They often target specific cellular components or pathways, leading to tissue damage and inflammation. Some examples of exotoxins include botulinum toxin produced by Clostridium botulinum, which causes botulism; diphtheria toxin produced by Corynebacterium diphtheriae, which causes diphtheria; and tetanus toxin produced by Clostridium tetani, which causes tetanus.

Endotoxins, on the other hand, are components of the bacterial cell wall that are released when the bacteria die or divide. They consist of lipopolysaccharides (LPS) and can cause a generalized inflammatory response in the host. Endotoxins can be found in gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa.

Bacterial toxins can cause a wide range of symptoms depending on the type of toxin, the dose, and the site of infection. They can lead to serious illnesses or even death if left untreated. Vaccines and antibiotics are often used to prevent or treat bacterial infections and reduce the risk of severe complications from bacterial toxins.

"Genomic Islands" are horizontally acquired DNA segments in bacterial and archaeal genomes that exhibit distinct features, such as different nucleotide composition (e.g., GC content) and codon usage compared to the rest of the genome. They often contain genes associated with mobile genetic elements, such as transposons, integrases, and phages, and are enriched for functions related to adaptive traits like antibiotic resistance, heavy metal tolerance, and virulence factors. These islands can be transferred between different strains or species through various mechanisms of horizontal gene transfer (HGT), including conjugation, transformation, and transduction, contributing significantly to bacterial evolution and diversity.

'C3H' is the name of an inbred strain of laboratory mice that was developed at the Jackson Laboratory in Bar Harbor, Maine. The mice are characterized by their uniform genetic background and have been widely used in biomedical research for many decades.

The C3H strain is particularly notable for its susceptibility to certain types of cancer, including mammary tumors and lymphomas. It also has a high incidence of age-related macular degeneration and other eye diseases. The strain is often used in studies of immunology, genetics, and carcinogenesis.

Like all inbred strains, the C3H mice are the result of many generations of brother-sister matings, which leads to a high degree of genetic uniformity within the strain. This makes them useful for studying the effects of specific genes or environmental factors on disease susceptibility and other traits. However, it also means that they may not always be representative of the genetic diversity found in outbred populations, including humans.

Bacteriuria is a medical term that refers to the presence of bacteria in the urine. The condition can be asymptomatic or symptomatic, and it can occur in various populations, including hospitalized patients, pregnant women, and individuals with underlying urologic abnormalities.

There are different types of bacteriuria, including:

1. Significant bacteriuria: This refers to the presence of a large number of bacteria in the urine (usually greater than 100,000 colony-forming units per milliliter or CFU/mL) and is often associated with urinary tract infection (UTI).
2. Contaminant bacteriuria: This occurs when bacteria from the skin or external environment enter the urine sample during collection, leading to a small number of bacteria present in the urine.
3. Asymptomatic bacteriuria: This refers to the presence of bacteria in the urine without any symptoms of UTI. It is more common in older adults, pregnant women, and individuals with diabetes or other underlying medical conditions.

The diagnosis of bacteriuria typically involves a urinalysis and urine culture to identify the type and quantity of bacteria present in the urine. Treatment depends on the type and severity of bacteriuria and may involve antibiotics to eliminate the infection. However, asymptomatic bacteriuria often does not require treatment unless it occurs in pregnant women or individuals undergoing urologic procedures.

The P blood group system is one of the rarest blood group systems in humans, with only a few antigens discovered so far. The main antigens in this system are P1 and P, which can be either present or absent on red blood cells (RBCs). The presence or absence of these antigens determines an individual's P blood group type.

The P1 antigen is a carbohydrate structure found on the surface of RBCs in individuals with the P1 phenotype, while those with the p phenotype lack this antigen. The P antigen is a protein found on the surface of RBCs in both P1 and p individuals.

Individuals with the P1 phenotype can develop antibodies against the P antigen if they are exposed to RBCs that lack the P1 antigen, such as those from a person with the p phenotype. Similarly, individuals with the p phenotype can develop antibodies against the P1 antigen if they are exposed to RBCs that have the P1 antigen.

Transfusion reactions can occur if an individual receives blood from a donor with a different P blood group type, leading to the destruction of RBCs and potentially life-threatening complications. Therefore, it is essential to determine an individual's P blood group type before transfusing blood or performing other medical procedures that involve RBCs.

Overall, the P blood group system is a complex and relatively rare system that requires careful consideration in medical settings to ensure safe and effective treatment.

Anti-bacterial agents, also known as antibiotics, are a type of medication used to treat infections caused by bacteria. These agents work by either killing the bacteria or inhibiting their growth and reproduction. There are several different classes of anti-bacterial agents, including penicillins, cephalosporins, fluoroquinolones, macrolides, and tetracyclines, among others. Each class of antibiotic has a specific mechanism of action and is used to treat certain types of bacterial infections. It's important to note that anti-bacterial agents are not effective against viral infections, such as the common cold or flu. Misuse and overuse of antibiotics can lead to antibiotic resistance, which is a significant global health concern.

Hemagglutinins are proteins found on the surface of some viruses, including influenza viruses. They have the ability to bind to specific receptors on the surface of red blood cells, causing them to clump together (a process known as hemagglutination). This property is what allows certain viruses to infect host cells and cause disease. Hemagglutinins play a crucial role in the infection process of influenza viruses, as they facilitate the virus's entry into host cells by binding to sialic acid receptors on the surface of respiratory epithelial cells. There are 18 different subtypes of hemagglutinin (H1-H18) found in various influenza A viruses, and they are a major target of the immune response to influenza infection. Vaccines against influenza contain hemagglutinins from the specific strains of virus that are predicted to be most prevalent in a given season, and induce immunity by stimulating the production of antibodies that can neutralize the virus.

Molecular cloning is a laboratory technique used to create multiple copies of a specific DNA sequence. This process involves several steps:

1. Isolation: The first step in molecular cloning is to isolate the DNA sequence of interest from the rest of the genomic DNA. This can be done using various methods such as PCR (polymerase chain reaction), restriction enzymes, or hybridization.
2. Vector construction: Once the DNA sequence of interest has been isolated, it must be inserted into a vector, which is a small circular DNA molecule that can replicate independently in a host cell. Common vectors used in molecular cloning include plasmids and phages.
3. Transformation: The constructed vector is then introduced into a host cell, usually a bacterial or yeast cell, through a process called transformation. This can be done using various methods such as electroporation or chemical transformation.
4. Selection: After transformation, the host cells are grown in selective media that allow only those cells containing the vector to grow. This ensures that the DNA sequence of interest has been successfully cloned into the vector.
5. Amplification: Once the host cells have been selected, they can be grown in large quantities to amplify the number of copies of the cloned DNA sequence.

Molecular cloning is a powerful tool in molecular biology and has numerous applications, including the production of recombinant proteins, gene therapy, functional analysis of genes, and genetic engineering.

Mannose is a simple sugar (monosaccharide) that is similar in structure to glucose. It is a hexose, meaning it contains six carbon atoms. Mannose is a stereoisomer of glucose, meaning it has the same chemical formula but a different structural arrangement of its atoms.

Mannose is not as commonly found in foods as other simple sugars, but it can be found in some fruits, such as cranberries, blueberries, and peaches, as well as in certain vegetables, like sweet potatoes and turnips. It is also found in some dietary fibers, such as those found in beans and whole grains.

In the body, mannose can be metabolized and used for energy, but it is also an important component of various glycoproteins and glycolipids, which are molecules that play critical roles in many biological processes, including cell recognition, signaling, and adhesion.

Mannose has been studied as a potential therapeutic agent for various medical conditions, including urinary tract infections (UTIs), because it can inhibit the attachment of certain bacteria to the cells lining the urinary tract. Additionally, mannose-binding lectins have been investigated for their potential role in the immune response to viral and bacterial infections.

Blood group antigens are molecular markers found on the surface of red blood cells (RBCs) and sometimes other types of cells in the body. These antigens are proteins, carbohydrates, or glycoproteins that can stimulate an immune response when foreign antigens are introduced into the body.

There are several different blood group systems, but the most well-known is the ABO system, which includes A, B, AB, and O blood groups. The antigens in this system are called ABO antigens. Individuals with type A blood have A antigens on their RBCs, those with type B blood have B antigens, those with type AB blood have both A and B antigens, and those with type O blood have neither A nor B antigens.

Another important blood group system is the Rh system, which includes the D antigen. Individuals who have this antigen are considered Rh-positive, while those who do not have it are considered Rh-negative.

Blood group antigens can cause complications during blood transfusions and pregnancy if there is a mismatch between the donor's or fetus's antigens and the recipient's antibodies. For example, if a person with type A blood receives type B blood, their anti-B antibodies will attack the foreign B antigens on the donated RBCs, causing a potentially life-threatening transfusion reaction. Similarly, if an Rh-negative woman becomes pregnant with an Rh-positive fetus, her immune system may produce anti-D antibodies that can cross the placenta and attack the fetal RBCs, leading to hemolytic disease of the newborn.

It is important for medical professionals to determine a patient's blood group before performing a transfusion or pregnancy-related procedures to avoid these complications.

Anti-infective agents for the urinary tract are medications used to prevent or treat infections caused by microorganisms (such as bacteria, fungi, or viruses) in the urinary system. These agents can be administered locally (for example, via catheter instillation) or systemically (orally or intravenously).

Common classes of anti-infective agents used for urinary tract infections include:

1. Antibiotics: These are the most commonly prescribed class of anti-infectives for urinary tract infections. They target and kill or inhibit the growth of bacteria responsible for the infection. Common antibiotics used for this purpose include trimethoprim-sulfamethoxazole, nitrofurantoin, ciprofloxacin, and fosfomycin.
2. Antifungals: These medications are used to treat fungal urinary tract infections (UTIs). Common antifungal agents include fluconazole, amphotericin B, and nystatin.
3. Antivirals: Although rare, viral UTIs can occur, and antiviral medications may be prescribed to treat them. Examples of antiviral agents used for urinary tract infections include acyclovir and valacyclovir.

It is essential to consult a healthcare professional for an accurate diagnosis and appropriate treatment for any suspected urinary tract infection. Improper use or misuse of anti-infective agents can lead to antibiotic resistance, making future treatments more challenging.

Female urogenital diseases refer to a range of medical conditions that affect the female urinary and genital systems. These systems include the kidneys, ureters, bladder, urethra, vulva, vagina, and reproductive organs such as the ovaries and uterus.

Some common female urogenital diseases include:

1. Urinary tract infections (UTIs): These are infections that occur in any part of the urinary system, including the kidneys, ureters, bladder, or urethra.
2. Pelvic inflammatory disease (PID): This is an infection of the reproductive organs, including the uterus, fallopian tubes, and ovaries.
3. Endometriosis: This is a condition in which tissue similar to the lining of the uterus grows outside of the uterus, often on the ovaries, fallopian tubes, or other pelvic structures.
4. Ovarian cysts: These are fluid-filled sacs that form on the ovaries.
5. Uterine fibroids: These are noncancerous growths that develop in the muscular wall of the uterus.
6. Interstitial cystitis/bladder pain syndrome (IC/BPS): This is a chronic bladder condition characterized by pain, pressure, and discomfort in the bladder and pelvic area.
7. Sexually transmitted infections (STIs): These are infections that are passed from person to person during sexual contact. Common STIs include chlamydia, gonorrhea, syphilis, and HIV.
8. Vulvodynia: This is chronic pain or discomfort of the vulva, the external female genital area.
9. Cancers of the reproductive system, such as ovarian cancer, cervical cancer, and uterine cancer.

These are just a few examples of female urogenital diseases. It's important for women to receive regular medical care and screenings to detect and treat these conditions early, when they are often easier to manage and have better outcomes.

A genetic complementation test is a laboratory procedure used in molecular genetics to determine whether two mutated genes can complement each other's function, indicating that they are located at different loci and represent separate alleles. This test involves introducing a normal or wild-type copy of one gene into a cell containing a mutant version of the same gene, and then observing whether the presence of the normal gene restores the normal function of the mutated gene. If the introduction of the normal gene results in the restoration of the normal phenotype, it suggests that the two genes are located at different loci and can complement each other's function. However, if the introduction of the normal gene does not restore the normal phenotype, it suggests that the two genes are located at the same locus and represent different alleles of the same gene. This test is commonly used to map genes and identify genetic interactions in a variety of organisms, including bacteria, yeast, and animals.

Trimethoprim-sulfamethoxazole combination is an antibiotic medication used to treat various bacterial infections. It contains two active ingredients: trimethoprim and sulfamethoxazole, which work together to inhibit the growth of bacteria by interfering with their ability to synthesize folic acid, a vital component for their survival.

Trimethoprim is a bacteriostatic agent that inhibits dihydrofolate reductase, an enzyme needed for bacterial growth, while sulfamethoxazole is a bacteriostatic sulfonamide that inhibits the synthesis of tetrahydrofolate by blocking the action of the enzyme bacterial dihydropteroate synthase. The combination of these two agents produces a synergistic effect, increasing the overall antibacterial activity of the medication.

Trimethoprim-sulfamethoxazole is commonly used to treat urinary tract infections, middle ear infections, bronchitis, traveler's diarrhea, and pneumocystis pneumonia (PCP), a severe lung infection that can occur in people with weakened immune systems. It is also used as a prophylactic treatment to prevent PCP in individuals with HIV/AIDS or other conditions that compromise the immune system.

As with any medication, trimethoprim-sulfamethoxazole combination can have side effects and potential risks, including allergic reactions, skin rashes, gastrointestinal symptoms, and blood disorders. It is essential to follow the prescribing physician's instructions carefully and report any adverse reactions promptly.

A "colony count" is a method used to estimate the number of viable microorganisms, such as bacteria or fungi, in a sample. In this technique, a known volume of the sample is spread onto the surface of a solid nutrient medium in a petri dish and then incubated under conditions that allow the microorganisms to grow and form visible colonies. Each colony that grows on the plate represents an individual cell (or small cluster of cells) from the original sample that was able to divide and grow under the given conditions. By counting the number of colonies that form, researchers can make a rough estimate of the concentration of microorganisms in the original sample.

The term "microbial" simply refers to microscopic organisms, such as bacteria, fungi, or viruses. Therefore, a "colony count, microbial" is a general term that encompasses the use of colony counting techniques to estimate the number of any type of microorganism in a sample.

Colony counts are used in various fields, including medical research, food safety testing, and environmental monitoring, to assess the levels of contamination or the effectiveness of disinfection procedures. However, it is important to note that colony counts may not always provide an accurate measure of the total number of microorganisms present in a sample, as some cells may be injured or unable to grow under the conditions used for counting. Additionally, some microorganisms may form clusters or chains that can appear as single colonies, leading to an overestimation of the true cell count.

Siderophores are low-molecular-weight organic compounds that are secreted by microorganisms, such as bacteria and fungi, to chelate and solubilize iron from their environment. They are able to bind ferric iron (Fe3+) with very high affinity and form a siderophore-iron complex, which can then be taken up by the microorganism through specific transport systems. This allows them to acquire iron even in environments where it is present at very low concentrations or in forms that are not readily available for uptake. Siderophores play an important role in the survival and virulence of many pathogenic microorganisms, as they help them to obtain the iron they need to grow and multiply.

Gene deletion is a type of mutation where a segment of DNA, containing one or more genes, is permanently lost or removed from a chromosome. This can occur due to various genetic mechanisms such as homologous recombination, non-homologous end joining, or other types of genomic rearrangements.

The deletion of a gene can have varying effects on the organism, depending on the function of the deleted gene and its importance for normal physiological processes. If the deleted gene is essential for survival, the deletion may result in embryonic lethality or developmental abnormalities. However, if the gene is non-essential or has redundant functions, the deletion may not have any noticeable effects on the organism's phenotype.

Gene deletions can also be used as a tool in genetic research to study the function of specific genes and their role in various biological processes. For example, researchers may use gene deletion techniques to create genetically modified animal models to investigate the impact of gene deletion on disease progression or development.

Flagella are long, thin, whip-like structures that some types of cells use to move themselves around. They are made up of a protein called tubulin and are surrounded by a membrane. In bacteria, flagella rotate like a propeller to push the cell through its environment. In eukaryotic cells (cells with a true nucleus), such as sperm cells or certain types of algae, flagella move in a wave-like motion to achieve locomotion. The ability to produce flagella is called flagellation.

Urinary bladder diseases refer to a range of conditions that affect the urinary bladder, a muscular sac located in the pelvis that stores urine before it is excreted from the body. These diseases can impair the bladder's ability to store or empty urine properly, leading to various symptoms and complications. Here are some common urinary bladder diseases with their medical definitions:

1. Cystitis: This is an inflammation of the bladder, often caused by bacterial infections (known as UTI - Urinary Tract Infection). However, it can also be triggered by irritants, radiation therapy, or chemical exposure.
2. Overactive Bladder (OAB): A group of symptoms that include urgency, frequency, and, in some cases, urge incontinence. The bladder muscle contracts excessively, causing a strong, sudden desire to urinate.
3. Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): A chronic bladder condition characterized by pain, pressure, or discomfort in the bladder and pelvic region, often accompanied by urinary frequency and urgency. Unlike cystitis, IC/BPS is not caused by infection, but its exact cause remains unknown.
4. Bladder Cancer: The abnormal growth of cancerous cells within the bladder lining or muscle. It can present as non-muscle-invasive (superficial) or muscle-invasive, depending on whether the tumor has grown into the bladder muscle.
5. Bladder Diverticula: Small sac-like pouches that form in the bladder lining and protrude outward through its wall. These may result from increased bladder pressure due to conditions like OAB or an enlarged prostate.
6. Neurogenic Bladder: A condition where nerve damage or dysfunction affects the bladder's ability to store or empty urine properly. This can lead to symptoms such as incontinence, urgency, and retention.
7. Benign Prostatic Hyperplasia (BPH): Although not a bladder disease itself, BPH is a common condition in older men where the prostate gland enlarges, putting pressure on the bladder and urethra, leading to urinary symptoms like frequency, urgency, and hesitancy.

Understanding these various bladder conditions can help individuals identify potential issues early on and seek appropriate medical attention for proper diagnosis and treatment.

DNA Sequence Analysis is the systematic determination of the order of nucleotides in a DNA molecule. It is a critical component of modern molecular biology, genetics, and genetic engineering. The process involves determining the exact order of the four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - in a DNA molecule or fragment. This information is used in various applications such as identifying gene mutations, studying evolutionary relationships, developing molecular markers for breeding, and diagnosing genetic diseases.

The process of DNA Sequence Analysis typically involves several steps, including DNA extraction, PCR amplification (if necessary), purification, sequencing reaction, and electrophoresis. The resulting data is then analyzed using specialized software to determine the exact sequence of nucleotides.

In recent years, high-throughput DNA sequencing technologies have revolutionized the field of genomics, enabling the rapid and cost-effective sequencing of entire genomes. This has led to an explosion of genomic data and new insights into the genetic basis of many diseases and traits.

Bacterial drug resistance is a type of antimicrobial resistance that occurs when bacteria evolve the ability to survive and reproduce in the presence of drugs (such as antibiotics) that would normally kill them or inhibit their growth. This can happen due to various mechanisms, including genetic mutations or the acquisition of resistance genes from other bacteria.

As a result, bacterial infections may become more difficult to treat, requiring higher doses of medication, alternative drugs, or longer treatment courses. In some cases, drug-resistant infections can lead to serious health complications, increased healthcare costs, and higher mortality rates.

Examples of bacterial drug resistance include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and multidrug-resistant tuberculosis (MDR-TB). Preventing the spread of bacterial drug resistance is crucial for maintaining effective treatments for infectious diseases.

Trimethoprim is an antibiotic medication that is primarily used to treat bacterial infections. It works by inhibiting the bacterial enzyme dihydrofolate reductase, which is necessary for the synthesis of DNA and protein. This leads to bacterial cell death. Trimethoprim is often combined with sulfamethoxazole (a sulfonamide antibiotic) to create a more effective antibacterial therapy known as co-trimoxazole or TMP-SMX.

Medical Definition:
Trimethoprim is a synthetic antibacterial drug that selectively inhibits bacterial dihydrofolate reductase, an enzyme required for the synthesis of tetrahydrofolate, a cofactor involved in the biosynthesis of thymidine and purines. By blocking this essential pathway, trimethoprim disrupts bacterial DNA and protein synthesis, leading to bacteriostatic activity against many gram-positive and gram-negative bacteria. Trimethoprim is often combined with sulfamethoxazole (a sulfonamide antibiotic) to create a more effective antibacterial therapy known as co-trimoxazole or TMP-SMX, which inhibits two consecutive steps in the bacterial folate synthesis pathway.

Bacterial antigens are substances found on the surface or produced by bacteria that can stimulate an immune response in a host organism. These antigens can be proteins, polysaccharides, teichoic acids, lipopolysaccharides, or other molecules that are recognized as foreign by the host's immune system.

When a bacterial antigen is encountered by the host's immune system, it triggers a series of responses aimed at eliminating the bacteria and preventing infection. The host's immune system recognizes the antigen as foreign through the use of specialized receptors called pattern recognition receptors (PRRs), which are found on various immune cells such as macrophages, dendritic cells, and neutrophils.

Once a bacterial antigen is recognized by the host's immune system, it can stimulate both the innate and adaptive immune responses. The innate immune response involves the activation of inflammatory pathways, the recruitment of immune cells to the site of infection, and the production of antimicrobial peptides.

The adaptive immune response, on the other hand, involves the activation of T cells and B cells, which are specific to the bacterial antigen. These cells can recognize and remember the antigen, allowing for a more rapid and effective response upon subsequent exposures.

Bacterial antigens are important in the development of vaccines, as they can be used to stimulate an immune response without causing disease. By identifying specific bacterial antigens that are associated with virulence or pathogenicity, researchers can develop vaccines that target these antigens and provide protection against infection.

Microbial sensitivity tests, also known as antibiotic susceptibility tests (ASTs) or bacterial susceptibility tests, are laboratory procedures used to determine the effectiveness of various antimicrobial agents against specific microorganisms isolated from a patient's infection. These tests help healthcare providers identify which antibiotics will be most effective in treating an infection and which ones should be avoided due to resistance. The results of these tests can guide appropriate antibiotic therapy, minimize the potential for antibiotic resistance, improve clinical outcomes, and reduce unnecessary side effects or toxicity from ineffective antimicrobials.

There are several methods for performing microbial sensitivity tests, including:

1. Disk diffusion method (Kirby-Bauer test): A standardized paper disk containing a predetermined amount of an antibiotic is placed on an agar plate that has been inoculated with the isolated microorganism. After incubation, the zone of inhibition around the disk is measured to determine the susceptibility or resistance of the organism to that particular antibiotic.
2. Broth dilution method: A series of tubes or wells containing decreasing concentrations of an antimicrobial agent are inoculated with a standardized microbial suspension. After incubation, the minimum inhibitory concentration (MIC) is determined by observing the lowest concentration of the antibiotic that prevents visible growth of the organism.
3. Automated systems: These use sophisticated technology to perform both disk diffusion and broth dilution methods automatically, providing rapid and accurate results for a wide range of microorganisms and antimicrobial agents.

The interpretation of microbial sensitivity test results should be done cautiously, considering factors such as the site of infection, pharmacokinetics and pharmacodynamics of the antibiotic, potential toxicity, and local resistance patterns. Regular monitoring of susceptibility patterns and ongoing antimicrobial stewardship programs are essential to ensure optimal use of these tests and to minimize the development of antibiotic resistance.

Epithelial cells are types of cells that cover the outer surfaces of the body, line the inner surfaces of organs and glands, and form the lining of blood vessels and body cavities. They provide a protective barrier against the external environment, regulate the movement of materials between the internal and external environments, and are involved in the sense of touch, temperature, and pain. Epithelial cells can be squamous (flat and thin), cuboidal (square-shaped and of equal height), or columnar (tall and narrow) in shape and are classified based on their location and function.

Bacterial chromosomes are typically circular, double-stranded DNA molecules that contain the genetic material of bacteria. Unlike eukaryotic cells, which have their DNA housed within a nucleus, bacterial chromosomes are located in the cytoplasm of the cell, often associated with the bacterial nucleoid.

Bacterial chromosomes can vary in size and structure among different species, but they typically contain all of the genetic information necessary for the survival and reproduction of the organism. They may also contain plasmids, which are smaller circular DNA molecules that can carry additional genes and can be transferred between bacteria through a process called conjugation.

One important feature of bacterial chromosomes is their ability to replicate rapidly, allowing bacteria to divide quickly and reproduce in large numbers. The replication of the bacterial chromosome begins at a specific origin point and proceeds in opposite directions until the entire chromosome has been copied. This process is tightly regulated and coordinated with cell division to ensure that each daughter cell receives a complete copy of the genetic material.

Overall, the study of bacterial chromosomes is an important area of research in microbiology, as understanding their structure and function can provide insights into bacterial genetics, evolution, and pathogenesis.

Hemagglutination tests are laboratory procedures used to detect the presence of antibodies or antigens in a sample, typically in blood serum. These tests rely on the ability of certain substances, such as viruses or bacteria, to agglutinate (clump together) red blood cells.

In a hemagglutination test, a small amount of the patient's serum is mixed with a known quantity of red blood cells that have been treated with a specific antigen. If the patient has antibodies against that antigen in their serum, they will bind to the antigens on the red blood cells and cause them to agglutinate. This clumping can be observed visually, indicating a positive test result.

Hemagglutination tests are commonly used to diagnose infectious diseases caused by viruses or bacteria that have hemagglutinating properties, such as influenza, parainfluenza, and HIV. They can also be used in blood typing and cross-matching before transfusions.

A bacterial genome is the complete set of genetic material, including both DNA and RNA, found within a single bacterium. It contains all the hereditary information necessary for the bacterium to grow, reproduce, and survive in its environment. The bacterial genome typically includes circular chromosomes, as well as plasmids, which are smaller, circular DNA molecules that can carry additional genes. These genes encode various functional elements such as enzymes, structural proteins, and regulatory sequences that determine the bacterium's characteristics and behavior.

Bacterial genomes vary widely in size, ranging from around 130 kilobases (kb) in Mycoplasma genitalium to over 14 megabases (Mb) in Sorangium cellulosum. The complete sequencing and analysis of bacterial genomes have provided valuable insights into the biology, evolution, and pathogenicity of bacteria, enabling researchers to better understand their roles in various diseases and potential applications in biotechnology.

Phylogeny is the evolutionary history and relationship among biological entities, such as species or genes, based on their shared characteristics. In other words, it refers to the branching pattern of evolution that shows how various organisms have descended from a common ancestor over time. Phylogenetic analysis involves constructing a tree-like diagram called a phylogenetic tree, which depicts the inferred evolutionary relationships among organisms or genes based on molecular sequence data or other types of characters. This information is crucial for understanding the diversity and distribution of life on Earth, as well as for studying the emergence and spread of diseases.

Agglutination tests are laboratory diagnostic procedures used to detect the presence of antibodies or antigens in a sample, such as blood or serum. These tests work by observing the clumping (agglutination) of particles, like red blood cells or bacteriophages, coated with specific antigens or antibodies when mixed with a patient's sample.

In an agglutination test, the sample is typically combined with a reagent containing known antigens or antibodies on the surface of particles, such as latex beads, red blood cells, or bacteriophages. If the sample contains the corresponding antibodies or antigens, they will bind to the particles, forming visible clumps or agglutinates. The presence and strength of agglutination are then assessed visually or with automated equipment to determine the presence and quantity of the target antigen or antibody in the sample.

Agglutination tests are widely used in medical diagnostics for various applications, including:

1. Bacterial and viral infections: To identify specific bacterial or viral antigens in a patient's sample, such as group A Streptococcus, Legionella pneumophila, or HIV.
2. Blood typing: To determine the ABO blood group and Rh type of a donor or recipient before a blood transfusion or organ transplantation.
3. Autoimmune diseases: To detect autoantibodies in patients with suspected autoimmune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, or Hashimoto's thyroiditis.
4. Allergies: To identify specific IgE antibodies in a patient's sample to determine allergic reactions to various substances, such as pollen, food, or venom.
5. Drug monitoring: To detect and quantify the presence of drug-induced antibodies, such as those developed in response to penicillin or hydralazine therapy.

Agglutination tests are simple, rapid, and cost-effective diagnostic tools that provide valuable information for clinical decision-making and patient management. However, they may have limitations, including potential cross-reactivity with other antigens, false-positive results due to rheumatoid factors or heterophile antibodies, and false-negative results due to the prozone effect or insufficient sensitivity. Therefore, it is essential to interpret agglutination test results in conjunction with clinical findings and other laboratory data.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

DNA transposable elements, also known as transposons or jumping genes, are mobile genetic elements that can change their position within a genome. They are composed of DNA sequences that include genes encoding the enzymes required for their own movement (transposase) and regulatory elements. When activated, the transposase recognizes specific sequences at the ends of the element and catalyzes the excision and reintegration of the transposable element into a new location in the genome. This process can lead to genetic variation, as the insertion of a transposable element can disrupt the function of nearby genes or create new combinations of gene regulatory elements. Transposable elements are widespread in both prokaryotic and eukaryotic genomes and are thought to play a significant role in genome evolution.

Bacterial typing techniques are methods used to identify and differentiate bacterial strains or isolates based on their unique characteristics. These techniques are essential in epidemiological studies, infection control, and research to understand the transmission dynamics, virulence, and antibiotic resistance patterns of bacterial pathogens.

There are various bacterial typing techniques available, including:

1. **Bacteriophage Typing:** This method involves using bacteriophages (viruses that infect bacteria) to identify specific bacterial strains based on their susceptibility or resistance to particular phages.
2. **Serotyping:** It is a technique that differentiates bacterial strains based on the antigenic properties of their cell surface components, such as capsules, flagella, and somatic (O) and flagellar (H) antigens.
3. **Biochemical Testing:** This method uses biochemical reactions to identify specific metabolic pathways or enzymes present in bacterial strains, which can be used for differentiation. Commonly used tests include the catalase test, oxidase test, and various sugar fermentation tests.
4. **Molecular Typing Techniques:** These methods use genetic markers to identify and differentiate bacterial strains at the DNA level. Examples of molecular typing techniques include:
* **Pulsed-Field Gel Electrophoresis (PFGE):** This method uses restriction enzymes to digest bacterial DNA, followed by electrophoresis in an agarose gel under pulsed electrical fields. The resulting banding patterns are analyzed and compared to identify related strains.
* **Multilocus Sequence Typing (MLST):** It involves sequencing specific housekeeping genes to generate unique sequence types that can be used for strain identification and phylogenetic analysis.
* **Whole Genome Sequencing (WGS):** This method sequences the entire genome of a bacterial strain, providing the most detailed information on genetic variation and relatedness between strains. WGS data can be analyzed using various bioinformatics tools to identify single nucleotide polymorphisms (SNPs), gene deletions or insertions, and other genetic changes that can be used for strain differentiation.

These molecular typing techniques provide higher resolution than traditional methods, allowing for more accurate identification and comparison of bacterial strains. They are particularly useful in epidemiological investigations to track the spread of pathogens and identify outbreaks.

Bacterial RNA refers to the genetic material present in bacteria that is composed of ribonucleic acid (RNA). Unlike higher organisms, bacteria contain a single circular chromosome made up of DNA, along with smaller circular pieces of DNA called plasmids. These bacterial genetic materials contain the information necessary for the growth and reproduction of the organism.

Bacterial RNA can be divided into three main categories: messenger RNA (mRNA), ribosomal RNA (rRNA), and transfer RNA (tRNA). mRNA carries genetic information copied from DNA, which is then translated into proteins by the rRNA and tRNA molecules. rRNA is a structural component of the ribosome, where protein synthesis occurs, while tRNA acts as an adapter that brings amino acids to the ribosome during protein synthesis.

Bacterial RNA plays a crucial role in various cellular processes, including gene expression, protein synthesis, and regulation of metabolic pathways. Understanding the structure and function of bacterial RNA is essential for developing new antibiotics and other therapeutic strategies to combat bacterial infections.

Recombinant proteins are artificially created proteins produced through the use of recombinant DNA technology. This process involves combining DNA molecules from different sources to create a new set of genes that encode for a specific protein. The resulting recombinant protein can then be expressed, purified, and used for various applications in research, medicine, and industry.

Recombinant proteins are widely used in biomedical research to study protein function, structure, and interactions. They are also used in the development of diagnostic tests, vaccines, and therapeutic drugs. For example, recombinant insulin is a common treatment for diabetes, while recombinant human growth hormone is used to treat growth disorders.

The production of recombinant proteins typically involves the use of host cells, such as bacteria, yeast, or mammalian cells, which are engineered to express the desired protein. The host cells are transformed with a plasmid vector containing the gene of interest, along with regulatory elements that control its expression. Once the host cells are cultured and the protein is expressed, it can be purified using various chromatography techniques.

Overall, recombinant proteins have revolutionized many areas of biology and medicine, enabling researchers to study and manipulate proteins in ways that were previously impossible.

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

Multiple bacterial drug resistance (MDR) is a medical term that refers to the resistance of multiple strains of bacteria to several antibiotics or antimicrobial agents. This means that these bacteria have developed mechanisms that enable them to survive and multiply despite being exposed to drugs that were previously effective in treating infections caused by them.

MDR is a significant public health concern because it limits the treatment options available for bacterial infections, making them more difficult and expensive to treat. In some cases, MDR bacteria may cause severe or life-threatening infections that are resistant to all available antibiotics, leaving doctors with few or no effective therapeutic options.

MDR can arise due to various mechanisms, including the production of enzymes that inactivate antibiotics, changes in bacterial cell membrane permeability that prevent antibiotics from entering the bacteria, and the development of efflux pumps that expel antibiotics out of the bacteria. The misuse or overuse of antibiotics is a significant contributor to the emergence and spread of MDR bacteria.

Preventing and controlling the spread of MDR bacteria requires a multifaceted approach, including the judicious use of antibiotics, infection control measures, surveillance, and research into new antimicrobial agents.

Molecular chaperones are a group of proteins that assist in the proper folding and assembly of other protein molecules, helping them achieve their native conformation. They play a crucial role in preventing protein misfolding and aggregation, which can lead to the formation of toxic species associated with various neurodegenerative diseases. Molecular chaperones are also involved in protein transport across membranes, degradation of misfolded proteins, and protection of cells under stress conditions. Their function is generally non-catalytic and ATP-dependent, and they often interact with their client proteins in a transient manner.

In genetics, sequence alignment is the process of arranging two or more DNA, RNA, or protein sequences to identify regions of similarity or homology between them. This is often done using computational methods to compare the nucleotide or amino acid sequences and identify matching patterns, which can provide insight into evolutionary relationships, functional domains, or potential genetic disorders. The alignment process typically involves adjusting gaps and mismatches in the sequences to maximize the similarity between them, resulting in an aligned sequence that can be visually represented and analyzed.

Glycolipids are a type of lipid (fat) molecule that contain one or more sugar molecules attached to them. They are important components of cell membranes, where they play a role in cell recognition and signaling. Glycolipids are also found on the surface of some viruses and bacteria, where they can be recognized by the immune system as foreign invaders.

There are several different types of glycolipids, including cerebrosides, gangliosides, and globosides. These molecules differ in the number and type of sugar molecules they contain, as well as the structure of their lipid tails. Glycolipids are synthesized in the endoplasmic reticulum and Golgi apparatus of cells, and they are transported to the cell membrane through vesicles.

Abnormalities in glycolipid metabolism or structure have been implicated in a number of diseases, including certain types of cancer, neurological disorders, and autoimmune diseases. For example, mutations in genes involved in the synthesis of glycolipids can lead to conditions such as Tay-Sachs disease and Gaucher's disease, which are characterized by the accumulation of abnormal glycolipids in cells.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.

In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.

Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.

Polymerase Chain Reaction (PCR) is a laboratory technique used to amplify specific regions of DNA. It enables the production of thousands to millions of copies of a particular DNA sequence in a rapid and efficient manner, making it an essential tool in various fields such as molecular biology, medical diagnostics, forensic science, and research.

The PCR process involves repeated cycles of heating and cooling to separate the DNA strands, allow primers (short sequences of single-stranded DNA) to attach to the target regions, and extend these primers using an enzyme called Taq polymerase, resulting in the exponential amplification of the desired DNA segment.

In a medical context, PCR is often used for detecting and quantifying specific pathogens (viruses, bacteria, fungi, or parasites) in clinical samples, identifying genetic mutations or polymorphisms associated with diseases, monitoring disease progression, and evaluating treatment effectiveness.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

Coliphages are viruses that infect and replicate within certain species of bacteria that belong to the coliform group, particularly Escherichia coli (E. coli). These viruses are commonly found in water and soil environments and are frequently used as indicators of fecal contamination in water quality testing. Coliphages are not harmful to humans or animals, but their presence in water can suggest the potential presence of pathogenic bacteria or other microorganisms that may pose a health risk. There are two main types of coliphages: F-specific RNA coliphages and somatic (or non-F specific) DNA coliphages.

Membrane proteins are a type of protein that are embedded in the lipid bilayer of biological membranes, such as the plasma membrane of cells or the inner membrane of mitochondria. These proteins play crucial roles in various cellular processes, including:

1. Cell-cell recognition and signaling
2. Transport of molecules across the membrane (selective permeability)
3. Enzymatic reactions at the membrane surface
4. Energy transduction and conversion
5. Mechanosensation and signal transduction

Membrane proteins can be classified into two main categories: integral membrane proteins, which are permanently associated with the lipid bilayer, and peripheral membrane proteins, which are temporarily or loosely attached to the membrane surface. Integral membrane proteins can further be divided into three subcategories based on their topology:

1. Transmembrane proteins, which span the entire width of the lipid bilayer with one or more alpha-helices or beta-barrels.
2. Lipid-anchored proteins, which are covalently attached to lipids in the membrane via a glycosylphosphatidylinositol (GPI) anchor or other lipid modifications.
3. Monotopic proteins, which are partially embedded in the membrane and have one or more domains exposed to either side of the bilayer.

Membrane proteins are essential for maintaining cellular homeostasis and are targets for various therapeutic interventions, including drug development and gene therapy. However, their structural complexity and hydrophobicity make them challenging to study using traditional biochemical methods, requiring specialized techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and single-particle cryo-electron microscopy (cryo-EM).

Host-pathogen interactions refer to the complex and dynamic relationship between a living organism (the host) and a disease-causing agent (the pathogen). This interaction can involve various molecular, cellular, and physiological processes that occur between the two entities. The outcome of this interaction can determine whether the host will develop an infection or not, as well as the severity and duration of the illness.

During host-pathogen interactions, the pathogen may release virulence factors that allow it to evade the host's immune system, colonize tissues, and obtain nutrients for its survival and replication. The host, in turn, may mount an immune response to recognize and eliminate the pathogen, which can involve various mechanisms such as inflammation, phagocytosis, and the production of antimicrobial agents.

Understanding the intricacies of host-pathogen interactions is crucial for developing effective strategies to prevent and treat infectious diseases. This knowledge can help identify new targets for therapeutic interventions, inform vaccine design, and guide public health policies to control the spread of infectious agents.

Nucleic acid hybridization is a process in molecular biology where two single-stranded nucleic acids (DNA, RNA) with complementary sequences pair together to form a double-stranded molecule through hydrogen bonding. The strands can be from the same type of nucleic acid or different types (i.e., DNA-RNA or DNA-cDNA). This process is commonly used in various laboratory techniques, such as Southern blotting, Northern blotting, polymerase chain reaction (PCR), and microarray analysis, to detect, isolate, and analyze specific nucleic acid sequences. The hybridization temperature and conditions are critical to ensure the specificity of the interaction between the two strands.

Pulsed-field gel electrophoresis (PFGE) is a type of electrophoresis technique used in molecular biology to separate DNA molecules based on their size and conformation. In this method, the electric field is applied in varying directions, which allows for the separation of large DNA fragments that are difficult to separate using traditional gel electrophoresis methods.

The DNA sample is prepared by embedding it in a semi-solid matrix, such as agarose or polyacrylamide, and then subjected to an electric field that periodically changes direction. This causes the DNA molecules to reorient themselves in response to the changing electric field, which results in the separation of the DNA fragments based on their size and shape.

PFGE is a powerful tool for molecular biology research and has many applications, including the identification and characterization of bacterial pathogens, the analysis of genomic DNA, and the study of gene organization and regulation. It is also used in forensic science to analyze DNA evidence in criminal investigations.

Restriction mapping is a technique used in molecular biology to identify the location and arrangement of specific restriction endonuclease recognition sites within a DNA molecule. Restriction endonucleases are enzymes that cut double-stranded DNA at specific sequences, producing fragments of various lengths. By digesting the DNA with different combinations of these enzymes and analyzing the resulting fragment sizes through techniques such as agarose gel electrophoresis, researchers can generate a restriction map - a visual representation of the locations and distances between recognition sites on the DNA molecule. This information is crucial for various applications, including cloning, genome analysis, and genetic engineering.

X-ray crystallography is a technique used in structural biology to determine the three-dimensional arrangement of atoms in a crystal lattice. In this method, a beam of X-rays is directed at a crystal and diffracts, or spreads out, into a pattern of spots called reflections. The intensity and angle of each reflection are measured and used to create an electron density map, which reveals the position and type of atoms in the crystal. This information can be used to determine the molecular structure of a compound, including its shape, size, and chemical bonds. X-ray crystallography is a powerful tool for understanding the structure and function of biological macromolecules such as proteins and nucleic acids.

A gene is a specific sequence of nucleotides in DNA that carries genetic information. Genes are the fundamental units of heredity and are responsible for the development and function of all living organisms. They code for proteins or RNA molecules, which carry out various functions within cells and are essential for the structure, function, and regulation of the body's tissues and organs.

Each gene has a specific location on a chromosome, and each person inherits two copies of every gene, one from each parent. Variations in the sequence of nucleotides in a gene can lead to differences in traits between individuals, including physical characteristics, susceptibility to disease, and responses to environmental factors.

Medical genetics is the study of genes and their role in health and disease. It involves understanding how genes contribute to the development and progression of various medical conditions, as well as identifying genetic risk factors and developing strategies for prevention, diagnosis, and treatment.

Glycosphingolipids are a type of complex lipid molecule found in animal cell membranes, particularly in the outer leaflet of the plasma membrane. They consist of a hydrophobic ceramide backbone, which is composed of sphingosine and fatty acids, linked to one or more hydrophilic sugar residues, such as glucose or galactose.

Glycosphingolipids can be further classified into two main groups: neutral glycosphingolipids (which include cerebrosides and gangliosides) and acidic glycosphingolipids (which are primarily gangliosides). Glycosphingolipids play important roles in various cellular processes, including cell recognition, signal transduction, and cell adhesion.

Abnormalities in the metabolism or structure of glycosphingolipids have been implicated in several diseases, such as lysosomal storage disorders (e.g., Gaucher's disease, Fabry's disease) and certain types of cancer (e.g., ganglioside-expressing neuroblastoma).

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Ciprofloxacin is a fluoroquinolone antibiotic that is used to treat various types of bacterial infections, including respiratory, urinary, and skin infections. It works by inhibiting the bacterial DNA gyrase, which is an enzyme necessary for bacterial replication and transcription. This leads to bacterial cell death. Ciprofloxacin is available in oral and injectable forms and is usually prescribed to be taken twice a day. Common side effects include nausea, diarrhea, and headache. It may also cause serious adverse reactions such as tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. It is important to note that ciprofloxacin should not be used in patients with a history of hypersensitivity to fluoroquinolones and should be used with caution in patients with a history of seizures, brain injury, or other neurological conditions.

Sequence homology, amino acid, refers to the similarity in the order of amino acids in a protein or a portion of a protein between two or more species. This similarity can be used to infer evolutionary relationships and functional similarities between proteins. The higher the degree of sequence homology, the more likely it is that the proteins are related and have similar functions. Sequence homology can be determined through various methods such as pairwise alignment or multiple sequence alignment, which compare the sequences and calculate a score based on the number and type of matching amino acids.

DNA-binding proteins are a type of protein that have the ability to bind to DNA (deoxyribonucleic acid), the genetic material of organisms. These proteins play crucial roles in various biological processes, such as regulation of gene expression, DNA replication, repair and recombination.

The binding of DNA-binding proteins to specific DNA sequences is mediated by non-covalent interactions, including electrostatic, hydrogen bonding, and van der Waals forces. The specificity of binding is determined by the recognition of particular nucleotide sequences or structural features of the DNA molecule.

DNA-binding proteins can be classified into several categories based on their structure and function, such as transcription factors, histones, and restriction enzymes. Transcription factors are a major class of DNA-binding proteins that regulate gene expression by binding to specific DNA sequences in the promoter region of genes and recruiting other proteins to modulate transcription. Histones are DNA-binding proteins that package DNA into nucleosomes, the basic unit of chromatin structure. Restriction enzymes are DNA-binding proteins that recognize and cleave specific DNA sequences, and are widely used in molecular biology research and biotechnology applications.

Electron microscopy (EM) is a type of microscopy that uses a beam of electrons to create an image of the sample being examined, resulting in much higher magnification and resolution than light microscopy. There are several types of electron microscopy, including transmission electron microscopy (TEM), scanning electron microscopy (SEM), and reflection electron microscopy (REM).

In TEM, a beam of electrons is transmitted through a thin slice of the sample, and the electrons that pass through the sample are focused to form an image. This technique can provide detailed information about the internal structure of cells, viruses, and other biological specimens, as well as the composition and structure of materials at the atomic level.

In SEM, a beam of electrons is scanned across the surface of the sample, and the electrons that are scattered back from the surface are detected to create an image. This technique can provide information about the topography and composition of surfaces, as well as the structure of materials at the microscopic level.

REM is a variation of SEM in which the beam of electrons is reflected off the surface of the sample, rather than scattered back from it. This technique can provide information about the surface chemistry and composition of materials.

Electron microscopy has a wide range of applications in biology, medicine, and materials science, including the study of cellular structure and function, disease diagnosis, and the development of new materials and technologies.

Enterotoxigenic Escherichia coli (ETEC) is a type of diarrheagenic E. coli that causes traveler's diarrhea and diarrheal diseases in infants in developing countries. It produces one or two enterotoxins, known as heat-labile toxin (LT) and heat-stable toxin (ST), which cause the intestinal lining to secrete large amounts of water and electrolytes, resulting in watery diarrhea. ETEC is often transmitted through contaminated food or water and is a common cause of traveler's diarrhea in people traveling to areas with poor sanitation. It can also cause outbreaks in refugee camps, nursing homes, and other institutional settings. Prevention measures include avoiding consumption of untreated water and raw or undercooked foods, as well as practicing good personal hygiene.

Neutrophils are a type of white blood cell that are part of the immune system's response to infection. They are produced in the bone marrow and released into the bloodstream where they circulate and are able to move quickly to sites of infection or inflammation in the body. Neutrophils are capable of engulfing and destroying bacteria, viruses, and other foreign substances through a process called phagocytosis. They are also involved in the release of inflammatory mediators, which can contribute to tissue damage in some cases. Neutrophils are characterized by the presence of granules in their cytoplasm, which contain enzymes and other proteins that help them carry out their immune functions.

Cell surface receptors, also known as membrane receptors, are proteins located on the cell membrane that bind to specific molecules outside the cell, known as ligands. These receptors play a crucial role in signal transduction, which is the process of converting an extracellular signal into an intracellular response.

Cell surface receptors can be classified into several categories based on their structure and mechanism of action, including:

1. Ion channel receptors: These receptors contain a pore that opens to allow ions to flow across the cell membrane when they bind to their ligands. This ion flux can directly activate or inhibit various cellular processes.
2. G protein-coupled receptors (GPCRs): These receptors consist of seven transmembrane domains and are associated with heterotrimeric G proteins that modulate intracellular signaling pathways upon ligand binding.
3. Enzyme-linked receptors: These receptors possess an intrinsic enzymatic activity or are linked to an enzyme, which becomes activated when the receptor binds to its ligand. This activation can lead to the initiation of various signaling cascades within the cell.
4. Receptor tyrosine kinases (RTKs): These receptors contain intracellular tyrosine kinase domains that become activated upon ligand binding, leading to the phosphorylation and activation of downstream signaling molecules.
5. Integrins: These receptors are transmembrane proteins that mediate cell-cell or cell-matrix interactions by binding to extracellular matrix proteins or counter-receptors on adjacent cells. They play essential roles in cell adhesion, migration, and survival.

Cell surface receptors are involved in various physiological processes, including neurotransmission, hormone signaling, immune response, and cell growth and differentiation. Dysregulation of these receptors can contribute to the development of numerous diseases, such as cancer, diabetes, and neurological disorders.

In the context of medicine, iron is an essential micromineral and key component of various proteins and enzymes. It plays a crucial role in oxygen transport, DNA synthesis, and energy production within the body. Iron exists in two main forms: heme and non-heme. Heme iron is derived from hemoglobin and myoglobin in animal products, while non-heme iron comes from plant sources and supplements.

The recommended daily allowance (RDA) for iron varies depending on age, sex, and life stage:

* For men aged 19-50 years, the RDA is 8 mg/day
* For women aged 19-50 years, the RDA is 18 mg/day
* During pregnancy, the RDA increases to 27 mg/day
* During lactation, the RDA for breastfeeding mothers is 9 mg/day

Iron deficiency can lead to anemia, characterized by fatigue, weakness, and shortness of breath. Excessive iron intake may result in iron overload, causing damage to organs such as the liver and heart. Balanced iron levels are essential for maintaining optimal health.

Tertiary protein structure refers to the three-dimensional arrangement of all the elements (polypeptide chains) of a single protein molecule. It is the highest level of structural organization and results from interactions between various side chains (R groups) of the amino acids that make up the protein. These interactions, which include hydrogen bonds, ionic bonds, van der Waals forces, and disulfide bridges, give the protein its unique shape and stability, which in turn determines its function. The tertiary structure of a protein can be stabilized by various factors such as temperature, pH, and the presence of certain ions. Any changes in these factors can lead to denaturation, where the protein loses its tertiary structure and thus its function.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Shiga-toxigenic Escherichia coli (STEC) are strains of the bacterium E. coli that produce one or both of two potent toxins called Shiga toxin or Shiga-like toxin. These toxins are named after Shigella dysenteriae type 1, from which the STEC Shiga toxin was originally isolated. The Shiga toxins cause severe damage to the lining of intestines and can lead to a range of symptoms such as diarrhea (often bloody), stomach cramps, vomiting, and fever. In severe cases, it can progress to hemolytic uremic syndrome (HUS), a serious complication that can cause kidney failure, brain damage, and even death, particularly in young children, the elderly, and immunocompromised individuals.

STEC is often found in the intestines of healthy animals, especially ruminants like cattle, goats, and sheep, and can be transmitted to humans through contaminated food or water, or direct contact with infected animals or their feces. Common sources of STEC include undercooked ground beef, raw milk, contaminated vegetables, and unpasteurized dairy products. It's important to note that not all strains of E. coli are Shiga-toxigenic, and only a small percentage of STEC infections result in severe illness or HUS.

Escherichia coli (E. coli) vaccines are designed to protect against infections caused by various strains of the E. coli bacterium. These vaccines typically contain inactivated or attenuated (weakened) forms of the bacteria, which stimulate an immune response when introduced into the body. The immune system learns to recognize and fight off the specific strain of E. coli used in the vaccine, providing protection against future infections with that strain.

There are several types of E. coli vaccines available or in development, including:

1. Shiga toxin-producing E. coli (STEC) vaccines: These vaccines protect against STEC strains, such as O157:H7 and non-O157 STECs, which can cause severe illness, including hemorrhagic colitis and hemolytic uremic syndrome (HUS).
2. Enterotoxigenic E. coli (ETEC) vaccines: These vaccines target ETEC strains that are a common cause of traveler's diarrhea in people visiting areas with poor sanitation.
3. Enteropathogenic E. coli (EPEC) vaccines: EPEC strains can cause persistent diarrhea, especially in young children in developing countries. Vaccines against these strains are still in the research and development stage.
4. Extraintestinal pathogenic E. coli (ExPEC) vaccines: These vaccines aim to protect against ExPEC strains that can cause urinary tract infections, sepsis, and meningitis.

It is important to note that different E. coli vaccines are designed for specific purposes and may not provide cross-protection against other strains or types of E. coli infections.

Culture media is a substance that is used to support the growth of microorganisms or cells in an artificial environment, such as a petri dish or test tube. It typically contains nutrients and other factors that are necessary for the growth and survival of the organisms being cultured. There are many different types of culture media, each with its own specific formulation and intended use. Some common examples include blood agar, which is used to culture bacteria; Sabouraud dextrose agar, which is used to culture fungi; and Eagle's minimum essential medium, which is used to culture animal cells.

Temperature, in a medical context, is a measure of the degree of hotness or coldness of a body or environment. It is usually measured using a thermometer and reported in degrees Celsius (°C), degrees Fahrenheit (°F), or kelvin (K). In the human body, normal core temperature ranges from about 36.5-37.5°C (97.7-99.5°F) when measured rectally, and can vary slightly depending on factors such as time of day, physical activity, and menstrual cycle. Elevated body temperature is a common sign of infection or inflammation, while abnormally low body temperature can indicate hypothermia or other medical conditions.

Enteropathogenic Escherichia coli (EPEC) are a type of bacteria that can cause diarrheal illness in humans, particularly in children under the age of 2. These bacteria colonize and infect the small intestine, causing inflammation and damage to the intestinal lining. This results in a variety of symptoms, including watery diarrhea, abdominal cramps, vomiting, and fever.

EPEC are characterized by their ability to form attaching and effacing (A/E) lesions on intestinal cells. These lesions cause the cells to reorganize and form a structure called a pedestal, which helps the bacteria attach to the cell surface and evade the host's immune system. EPEC also produce toxins that can damage the intestinal lining and contribute to the development of diarrhea.

EPEC are transmitted through contaminated food and water, as well as person-to-person contact. They are a common cause of traveler's diarrhea and have been associated with outbreaks in child care centers and other settings where people are in close proximity to each other. Prevention measures include good hygiene practices, such as handwashing and proper food handling and preparation, as well as avoiding contaminated food and water sources.

Genotype, in genetics, refers to the complete heritable genetic makeup of an individual organism, including all of its genes. It is the set of instructions contained in an organism's DNA for the development and function of that organism. The genotype is the basis for an individual's inherited traits, and it can be contrasted with an individual's phenotype, which refers to the observable physical or biochemical characteristics of an organism that result from the expression of its genes in combination with environmental influences.

It is important to note that an individual's genotype is not necessarily identical to their genetic sequence. Some genes have multiple forms called alleles, and an individual may inherit different alleles for a given gene from each parent. The combination of alleles that an individual inherits for a particular gene is known as their genotype for that gene.

Understanding an individual's genotype can provide important information about their susceptibility to certain diseases, their response to drugs and other treatments, and their risk of passing on inherited genetic disorders to their offspring.

Innate immunity, also known as non-specific immunity or natural immunity, is the inherent defense mechanism that provides immediate protection against potentially harmful pathogens (like bacteria, viruses, fungi, and parasites) without the need for prior exposure. This type of immunity is present from birth and does not adapt to specific threats over time.

Innate immune responses involve various mechanisms such as:

1. Physical barriers: Skin and mucous membranes prevent pathogens from entering the body.
2. Chemical barriers: Enzymes, stomach acid, and lysozyme in tears, saliva, and sweat help to destroy or inhibit the growth of microorganisms.
3. Cellular responses: Phagocytic cells (neutrophils, monocytes, macrophages) recognize and engulf foreign particles and pathogens, while natural killer (NK) cells target and eliminate virus-infected or cancerous cells.
4. Inflammatory response: When an infection occurs, the innate immune system triggers inflammation to increase blood flow, recruit immune cells, and remove damaged tissue.
5. Complement system: A group of proteins that work together to recognize and destroy pathogens directly or enhance phagocytosis by coating them with complement components (opsonization).

Innate immunity plays a crucial role in initiating the adaptive immune response, which is specific to particular pathogens and provides long-term protection through memory cells. Both innate and adaptive immunity work together to maintain overall immune homeostasis and protect the body from infections and diseases.

Feces are the solid or semisolid remains of food that could not be digested or absorbed in the small intestine, along with bacteria and other waste products. After being stored in the colon, feces are eliminated from the body through the rectum and anus during defecation. Feces can vary in color, consistency, and odor depending on a person's diet, health status, and other factors.

Genetic transcription is the process by which the information in a strand of DNA is used to create a complementary RNA molecule. This process is the first step in gene expression, where the genetic code in DNA is converted into a form that can be used to produce proteins or functional RNAs.

During transcription, an enzyme called RNA polymerase binds to the DNA template strand and reads the sequence of nucleotide bases. As it moves along the template, it adds complementary RNA nucleotides to the growing RNA chain, creating a single-stranded RNA molecule that is complementary to the DNA template strand. Once transcription is complete, the RNA molecule may undergo further processing before it can be translated into protein or perform its functional role in the cell.

Transcription can be either "constitutive" or "regulated." Constitutive transcription occurs at a relatively constant rate and produces essential proteins that are required for basic cellular functions. Regulated transcription, on the other hand, is subject to control by various intracellular and extracellular signals, allowing cells to respond to changing environmental conditions or developmental cues.

Substrate specificity in the context of medical biochemistry and enzymology refers to the ability of an enzyme to selectively bind and catalyze a chemical reaction with a particular substrate (or a group of similar substrates) while discriminating against other molecules that are not substrates. This specificity arises from the three-dimensional structure of the enzyme, which has evolved to match the shape, charge distribution, and functional groups of its physiological substrate(s).

Substrate specificity is a fundamental property of enzymes that enables them to carry out highly selective chemical transformations in the complex cellular environment. The active site of an enzyme, where the catalysis takes place, has a unique conformation that complements the shape and charge distribution of its substrate(s). This ensures efficient recognition, binding, and conversion of the substrate into the desired product while minimizing unwanted side reactions with other molecules.

Substrate specificity can be categorized as:

1. Absolute specificity: An enzyme that can only act on a single substrate or a very narrow group of structurally related substrates, showing no activity towards any other molecule.
2. Group specificity: An enzyme that prefers to act on a particular functional group or class of compounds but can still accommodate minor structural variations within the substrate.
3. Broad or promiscuous specificity: An enzyme that can act on a wide range of structurally diverse substrates, albeit with varying catalytic efficiencies.

Understanding substrate specificity is crucial for elucidating enzymatic mechanisms, designing drugs that target specific enzymes or pathways, and developing biotechnological applications that rely on the controlled manipulation of enzyme activities.

Genetic conjugation is a type of genetic transfer that occurs between bacterial cells. It involves the process of one bacterium (the donor) transferring a piece of its DNA to another bacterium (the recipient) through direct contact or via a bridge-like connection called a pilus. This transferred DNA may contain genes that provide the recipient cell with new traits, such as antibiotic resistance or virulence factors, which can make the bacteria more harmful or difficult to treat. Genetic conjugation is an important mechanism for the spread of antibiotic resistance and other traits among bacterial populations.

Chromosome mapping, also known as physical mapping, is the process of determining the location and order of specific genes or genetic markers on a chromosome. This is typically done by using various laboratory techniques to identify landmarks along the chromosome, such as restriction enzyme cutting sites or patterns of DNA sequence repeats. The resulting map provides important information about the organization and structure of the genome, and can be used for a variety of purposes, including identifying the location of genes associated with genetic diseases, studying evolutionary relationships between organisms, and developing genetic markers for use in breeding or forensic applications.

Biological models, also known as physiological models or organismal models, are simplified representations of biological systems, processes, or mechanisms that are used to understand and explain the underlying principles and relationships. These models can be theoretical (conceptual or mathematical) or physical (such as anatomical models, cell cultures, or animal models). They are widely used in biomedical research to study various phenomena, including disease pathophysiology, drug action, and therapeutic interventions.

Examples of biological models include:

1. Mathematical models: These use mathematical equations and formulas to describe complex biological systems or processes, such as population dynamics, metabolic pathways, or gene regulation networks. They can help predict the behavior of these systems under different conditions and test hypotheses about their underlying mechanisms.
2. Cell cultures: These are collections of cells grown in a controlled environment, typically in a laboratory dish or flask. They can be used to study cellular processes, such as signal transduction, gene expression, or metabolism, and to test the effects of drugs or other treatments on these processes.
3. Animal models: These are living organisms, usually vertebrates like mice, rats, or non-human primates, that are used to study various aspects of human biology and disease. They can provide valuable insights into the pathophysiology of diseases, the mechanisms of drug action, and the safety and efficacy of new therapies.
4. Anatomical models: These are physical representations of biological structures or systems, such as plastic models of organs or tissues, that can be used for educational purposes or to plan surgical procedures. They can also serve as a basis for developing more sophisticated models, such as computer simulations or 3D-printed replicas.

Overall, biological models play a crucial role in advancing our understanding of biology and medicine, helping to identify new targets for therapeutic intervention, develop novel drugs and treatments, and improve human health.

Electrophoresis, polyacrylamide gel (EPG) is a laboratory technique used to separate and analyze complex mixtures of proteins or nucleic acids (DNA or RNA) based on their size and electrical charge. This technique utilizes a matrix made of cross-linked polyacrylamide, a type of gel, which provides a stable and uniform environment for the separation of molecules.

In this process:

1. The polyacrylamide gel is prepared by mixing acrylamide monomers with a cross-linking agent (bis-acrylamide) and a catalyst (ammonium persulfate) in the presence of a buffer solution.
2. The gel is then poured into a mold and allowed to polymerize, forming a solid matrix with uniform pore sizes that depend on the concentration of acrylamide used. Higher concentrations result in smaller pores, providing better resolution for separating smaller molecules.
3. Once the gel has set, it is placed in an electrophoresis apparatus containing a buffer solution. Samples containing the mixture of proteins or nucleic acids are loaded into wells on the top of the gel.
4. An electric field is applied across the gel, causing the negatively charged molecules to migrate towards the positive electrode (anode) while positively charged molecules move toward the negative electrode (cathode). The rate of migration depends on the size, charge, and shape of the molecules.
5. Smaller molecules move faster through the gel matrix and will migrate farther from the origin compared to larger molecules, resulting in separation based on size. Proteins and nucleic acids can be selectively stained after electrophoresis to visualize the separated bands.

EPG is widely used in various research fields, including molecular biology, genetics, proteomics, and forensic science, for applications such as protein characterization, DNA fragment analysis, cloning, mutation detection, and quality control of nucleic acid or protein samples.

A cell line is a culture of cells that are grown in a laboratory for use in research. These cells are usually taken from a single cell or group of cells, and they are able to divide and grow continuously in the lab. Cell lines can come from many different sources, including animals, plants, and humans. They are often used in scientific research to study cellular processes, disease mechanisms, and to test new drugs or treatments. Some common types of human cell lines include HeLa cells (which come from a cancer patient named Henrietta Lacks), HEK293 cells (which come from embryonic kidney cells), and HUVEC cells (which come from umbilical vein endothelial cells). It is important to note that cell lines are not the same as primary cells, which are cells that are taken directly from a living organism and have not been grown in the lab.

Proteus mirabilis is a species of Gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the environment, particularly in soil and water. In humans, P. mirabilis can be part of the normal gut flora but can also cause opportunistic infections, particularly in the urinary tract. It is known for its ability to produce urease, which can lead to the formation of urinary stones and blockages.

P. mirabilis infections are often associated with underlying medical conditions such as diabetes, kidney disease, or urinary catheterization. Symptoms of a P. mirabilis infection may include fever, cloudy or foul-smelling urine, and pain or burning during urination. Treatment typically involves antibiotics that are effective against Gram-negative bacteria, although resistance to certain antibiotics is not uncommon in P. mirabilis isolates.

"Escherichia" is a genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that are commonly found in the intestines of warm-blooded organisms. The most well-known species in this genus is "Escherichia coli," or "E. coli," which is a normal inhabitant of the human gut and is often used as an indicator of fecal contamination in water and food. Some strains of E. coli can cause illness, however, including diarrhea, urinary tract infections, and meningitis. Other species in the genus "Escherichia" are less well-known and are not typically associated with disease.

Epithelium is the tissue that covers the outer surface of the body, lines the internal cavities and organs, and forms various glands. It is composed of one or more layers of tightly packed cells that have a uniform shape and size, and rest on a basement membrane. Epithelial tissues are avascular, meaning they do not contain blood vessels, and are supplied with nutrients by diffusion from the underlying connective tissue.

Epithelial cells perform a variety of functions, including protection, secretion, absorption, excretion, and sensation. They can be classified based on their shape and the number of cell layers they contain. The main types of epithelium are:

1. Squamous epithelium: composed of flat, scalelike cells that fit together like tiles on a roof. It forms the lining of blood vessels, air sacs in the lungs, and the outermost layer of the skin.
2. Cuboidal epithelium: composed of cube-shaped cells with equal height and width. It is found in glands, tubules, and ducts.
3. Columnar epithelium: composed of tall, rectangular cells that are taller than they are wide. It lines the respiratory, digestive, and reproductive tracts.
4. Pseudostratified epithelium: appears stratified or layered but is actually made up of a single layer of cells that vary in height. The nuclei of these cells appear at different levels, giving the tissue a stratified appearance. It lines the respiratory and reproductive tracts.
5. Transitional epithelium: composed of several layers of cells that can stretch and change shape to accommodate changes in volume. It is found in the urinary bladder and ureters.

Epithelial tissue provides a barrier between the internal and external environments, protecting the body from physical, chemical, and biological damage. It also plays a crucial role in maintaining homeostasis by regulating the exchange of substances between the body and its environment.

Protein conformation refers to the specific three-dimensional shape that a protein molecule assumes due to the spatial arrangement of its constituent amino acid residues and their associated chemical groups. This complex structure is determined by several factors, including covalent bonds (disulfide bridges), hydrogen bonds, van der Waals forces, and ionic bonds, which help stabilize the protein's unique conformation.

Protein conformations can be broadly classified into two categories: primary, secondary, tertiary, and quaternary structures. The primary structure represents the linear sequence of amino acids in a polypeptide chain. The secondary structure arises from local interactions between adjacent amino acid residues, leading to the formation of recurring motifs such as α-helices and β-sheets. Tertiary structure refers to the overall three-dimensional folding pattern of a single polypeptide chain, while quaternary structure describes the spatial arrangement of multiple folded polypeptide chains (subunits) that interact to form a functional protein complex.

Understanding protein conformation is crucial for elucidating protein function, as the specific three-dimensional shape of a protein directly influences its ability to interact with other molecules, such as ligands, nucleic acids, or other proteins. Any alterations in protein conformation due to genetic mutations, environmental factors, or chemical modifications can lead to loss of function, misfolding, aggregation, and disease states like neurodegenerative disorders and cancer.

Enterohemorrhagic Escherichia coli (EHEC) are a type of Shiga toxin-producing E. coli (STEC). They are characterized by their ability to cause hemorrhagic diarrhea and the presence of a virulence factor known as Shiga toxin or Verocytotoxin. The most well-known serotype of EHEC is O157:H7, but there are other non-O157 serotypes that can also cause human illness.

EHEC infection typically occurs through the consumption of contaminated food or water, or direct contact with infected animals or their environment. Once ingested, EHEC colonize the intestines and produce Shiga toxins, which can damage the lining of the intestine and cause bloody diarrhea. In severe cases, Shiga toxins can also enter the bloodstream and cause hemolytic uremic syndrome (HUS), a serious complication that can lead to kidney failure and other long-term health problems.

Preventing EHEC infection involves practicing good food safety habits, such as washing hands thoroughly before preparing or eating food, cooking meats to the recommended internal temperature, avoiding unpasteurized dairy products and juices, and washing fruits and vegetables thoroughly before eating. It is also important to handle and store food properly to prevent cross-contamination with EHEC bacteria.

Recombinant fusion proteins are artificially created biomolecules that combine the functional domains or properties of two or more different proteins into a single protein entity. They are generated through recombinant DNA technology, where the genes encoding the desired protein domains are linked together and expressed as a single, chimeric gene in a host organism, such as bacteria, yeast, or mammalian cells.

The resulting fusion protein retains the functional properties of its individual constituent proteins, allowing for novel applications in research, diagnostics, and therapeutics. For instance, recombinant fusion proteins can be designed to enhance protein stability, solubility, or immunogenicity, making them valuable tools for studying protein-protein interactions, developing targeted therapies, or generating vaccines against infectious diseases or cancer.

Examples of recombinant fusion proteins include:

1. Etaglunatide (ABT-523): A soluble Fc fusion protein that combines the heavy chain fragment crystallizable region (Fc) of an immunoglobulin with the extracellular domain of the human interleukin-6 receptor (IL-6R). This fusion protein functions as a decoy receptor, neutralizing IL-6 and its downstream signaling pathways in rheumatoid arthritis.
2. Etanercept (Enbrel): A soluble TNF receptor p75 Fc fusion protein that binds to tumor necrosis factor-alpha (TNF-α) and inhibits its proinflammatory activity, making it a valuable therapeutic option for treating autoimmune diseases like rheumatoid arthritis, ankylosing spondylitis, and psoriasis.
3. Abatacept (Orencia): A fusion protein consisting of the extracellular domain of cytotoxic T-lymphocyte antigen 4 (CTLA-4) linked to the Fc region of an immunoglobulin, which downregulates T-cell activation and proliferation in autoimmune diseases like rheumatoid arthritis.
4. Belimumab (Benlysta): A monoclonal antibody that targets B-lymphocyte stimulator (BLyS) protein, preventing its interaction with the B-cell surface receptor and inhibiting B-cell activation in systemic lupus erythematosus (SLE).
5. Romiplostim (Nplate): A fusion protein consisting of a thrombopoietin receptor agonist peptide linked to an immunoglobulin Fc region, which stimulates platelet production in patients with chronic immune thrombocytopenia (ITP).
6. Darbepoetin alfa (Aranesp): A hyperglycosylated erythropoiesis-stimulating protein that functions as a longer-acting form of recombinant human erythropoietin, used to treat anemia in patients with chronic kidney disease or cancer.
7. Palivizumab (Synagis): A monoclonal antibody directed against the F protein of respiratory syncytial virus (RSV), which prevents RSV infection and is administered prophylactically to high-risk infants during the RSV season.
8. Ranibizumab (Lucentis): A recombinant humanized monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A (VEGF-A), used in the treatment of age-related macular degeneration, diabetic retinopathy, and other ocular disorders.
9. Cetuximab (Erbitux): A chimeric monoclonal antibody that binds to epidermal growth factor receptor (EGFR), used in the treatment of colorectal cancer and head and neck squamous cell carcinoma.
10. Adalimumab (Humira): A fully humanized monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), used in the treatment of various inflammatory diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease.
11. Bevacizumab (Avastin): A recombinant humanized monoclonal antibody that binds to VEGF-A, used in the treatment of various cancers, including colorectal, lung, breast, and kidney cancer.
12. Trastuzumab (Herceptin): A humanized monoclonal antibody that targets HER2/neu receptor, used in the treatment of breast cancer.
13. Rituximab (Rituxan): A chimeric monoclonal antibody that binds to CD20 antigen on B cells, used in the treatment of non-Hodgkin's lymphoma and rheumatoid arthritis.
14. Palivizumab (Synagis): A humanized monoclonal antibody that binds to the F protein of respiratory syncytial virus, used in the prevention of respiratory syncytial virus infection in high-risk infants.
15. Infliximab (Remicade): A chimeric monoclonal antibody that targets TNF-α, used in the treatment of various inflammatory diseases, including Crohn's disease, ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis.
16. Natalizumab (Tysabri): A humanized monoclonal antibody that binds to α4β1 integrin, used in the treatment of multiple sclerosis and Crohn's disease.
17. Adalimumab (Humira): A fully human monoclonal antibody that targets TNF-α, used in the treatment of various inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.
18. Golimumab (Simponi): A fully human monoclonal antibody that targets TNF-α, used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
19. Certolizumab pegol (Cimzia): A PEGylated Fab' fragment of a humanized monoclonal antibody that targets TNF-α, used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease.
20. Ustekinumab (Stelara): A fully human monoclonal antibody that targets IL-12 and IL-23, used in the treatment of psoriasis, psoriatic arthritis, and Crohn's disease.
21. Secukinumab (Cosentyx): A fully human monoclonal antibody that targets IL-17A, used in the treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis.
22. Ixekizumab (Taltz): A fully human monoclonal antibody that targets IL-17A, used in the treatment of psoriasis and psoriatic arthritis.
23. Brodalumab (Siliq): A fully human monoclonal antibody that targets IL-17 receptor A, used in the treatment of psoriasis.
24. Sarilumab (Kevzara): A fully human monoclonal antibody that targets the IL-6 receptor, used in the treatment of rheumatoid arthritis.
25. Tocilizumab (Actemra): A humanized monoclonal antibody that targets the IL-6 receptor, used in the treatment of rheumatoid arthritis, systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, giant cell arteritis, and chimeric antigen receptor T-cell-induced cytokine release syndrome.
26. Siltuximab (Sylvant): A chimeric monoclonal antibody that targets IL-6, used in the treatment of multicentric Castleman disease.
27. Satralizumab (Enspryng): A humanized monoclonal antibody that targets IL-6 receptor alpha, used in the treatment of neuromyelitis optica spectrum disorder.
28. Sirukumab (Plivensia): A human monoclonal antibody that targets IL-6, used in the treatment

Molecular weight, also known as molecular mass, is the mass of a molecule. It is expressed in units of atomic mass units (amu) or daltons (Da). Molecular weight is calculated by adding up the atomic weights of each atom in a molecule. It is a useful property in chemistry and biology, as it can be used to determine the concentration of a substance in a solution, or to calculate the amount of a substance that will react with another in a chemical reaction.

Carrier proteins, also known as transport proteins, are a type of protein that facilitates the movement of molecules across cell membranes. They are responsible for the selective and active transport of ions, sugars, amino acids, and other molecules from one side of the membrane to the other, against their concentration gradient. This process requires energy, usually in the form of ATP (adenosine triphosphate).

Carrier proteins have a specific binding site for the molecule they transport, and undergo conformational changes upon binding, which allows them to move the molecule across the membrane. Once the molecule has been transported, the carrier protein returns to its original conformation, ready to bind and transport another molecule.

Carrier proteins play a crucial role in maintaining the balance of ions and other molecules inside and outside of cells, and are essential for many physiological processes, including nerve impulse transmission, muscle contraction, and nutrient uptake.

Microbial drug resistance is a significant medical issue that refers to the ability of microorganisms (such as bacteria, viruses, fungi, or parasites) to withstand or survive exposure to drugs or medications designed to kill them or limit their growth. This phenomenon has become a major global health concern, particularly in the context of bacterial infections, where it is also known as antibiotic resistance.

Drug resistance arises due to genetic changes in microorganisms that enable them to modify or bypass the effects of antimicrobial agents. These genetic alterations can be caused by mutations or the acquisition of resistance genes through horizontal gene transfer. The resistant microbes then replicate and multiply, forming populations that are increasingly difficult to eradicate with conventional treatments.

The consequences of drug-resistant infections include increased morbidity, mortality, healthcare costs, and the potential for widespread outbreaks. Factors contributing to the emergence and spread of microbial drug resistance include the overuse or misuse of antimicrobials, poor infection control practices, and inadequate surveillance systems.

To address this challenge, it is crucial to promote prudent antibiotic use, strengthen infection prevention and control measures, develop new antimicrobial agents, and invest in research to better understand the mechanisms underlying drug resistance.

Beta-galactosidase is an enzyme that catalyzes the hydrolysis of beta-galactosides into monosaccharides. It is found in various organisms, including bacteria, yeast, and mammals. In humans, it plays a role in the breakdown and absorption of certain complex carbohydrates, such as lactose, in the small intestine. Deficiency of this enzyme in humans can lead to a disorder called lactose intolerance. In scientific research, beta-galactosidase is often used as a marker for gene expression and protein localization studies.

"DamX Controls Reversible Cell Morphology Switching in Uropathogenic Escherichia coli". mBio. 7 (4). doi:10.1128/mBio.00642-16. ... Filamentation is the anomalous growth of certain bacteria, such as Escherichia coli, in which cells continue to elongate but do ... Gill CO, Badoni M, Jones TH (November 2007). "Behaviours of log phase cultures of eight strains of Escherichia coli incubated ... Thymineless death and the recovery after re-addition of thymine in Escherichia coli K 12". European Journal of Biochemistry. 60 ...
... coli K-12. Uropathogenic Escherichia coli (UPEC) AlignACE Matrices that search for additional binding sites in the E. coli ... Wikispecies has information related to Escherichia coli. Wikimedia Commons has media related to Escherichia coli. EcoCyc - ... coli helped produce E. coli O157:H7, the Shiga toxin-producing strain of E. coli. E. coli encompasses an enormous population of ... "Uropathogenic Escherichia coli: The Pre-Eminent Urinary Tract Infection Pathogen". Nova publishers. Archived from the original ...
"Role of capsular colanic acid in adhesion of uropathogenic Escherichia coli". Applied and Environmental Microbiology. 69 (8): ... Wang C, Zhang H, Wang J, Chen S, Wang Z, Zhao L, Wang X (October 2020). "Colanic acid biosynthesis in Escherichia coli is ... Escherichia coli K-12 substr. MG1655 Sutherland IW (1990-10-18). Biotechnology of Microbial Exopolysaccharides. Cambridge ... Ebel, W.; Trempy, J. E. (January 1999). "Escherichia coli RcsA, a positive activator of colanic acid capsular polysaccharide ...
February 2020). "The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms". npj Biofilms ... Cecropin A can destroy planktonic and sessile biofilm-forming uropathogenic E. coli (UPEC) cells, either alone or when combined ... Some antimicrobial peptides kill both bacteria and fungi, e.g., psoriasin kills E. coli and several filamentous fungi. The ... coli. Bacteria use various resistance strategies to avoid antimicrobial peptide killing. Some microorganisms alter net surface ...
"The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms". npj Biofilms and Microbiomes. 6 ... Cecropin A can destroy planktonic and sessile biofilm-forming uropathogenic E. coli (UPEC) cells, either alone or when combined ...
December 2002). "Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli". ... Similarly, the three phenotypically diverse Escherichia coli strains (uropathogenic, enterohemorrhagic and benign) share about ... The analysis of a group of four Escherichia coli and two Shigella flexneri strains revealed that the sequence stretches common ... Tatum EL, Lederberg J (June 1947). "Gene Recombination in the Bacterium Escherichia coli". Journal of Bacteriology. 53 (6): 673 ...
"Isolation and characterization of uropathogenic Escherichia coli (UPEC) from Red Panda (Ailurus fulgens)". BMC Veterinary ... liver and lungs were damaged by a bacterial infection caused by Escherichia coli. The red panda is primarily threatened by the ...
"Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli". Infect. ... Kolling GL, Matthews KR (May 1999). "Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7 ... coli and Salmonella, it does not require the Hfq protein to regulate the sigma factor. It was also shown that VrrA ...
"The small RNA RyhB contributes to siderophore production and virulence of uropathogenic Escherichia coli". Infection and ... Zhang S, Liu S, Wu N, Yuan Y, Zhang W, Zhang Y (2018). "Escherichia coli by Reducing Cellular Metabolism". Frontiers in ... Massé E, Vanderpool CK, Gottesman S (October 2005). "Effect of RyhB small RNA on global iron use in Escherichia coli". Journal ... Urban JH, Vogel J (2007). "Translational control and target recognition by Escherichia coli small RNAs in vivo". Nucleic Acids ...
2002). "Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli". Proc. Natl. ... 2006). "Escherichia coli K-12: a cooperatively developed annotation snapshot-2005". Nucleic Acids Res. 34 (1): 1-9. doi:10.1093 ... 1997). "The complete genome sequence of Escherichia coli K-12". Science. 277 (5331): 1453-74. doi:10.1126/science.277.5331.1453 ... 2001). "Genome sequence of enterohaemorrhagic Escherichia coli O157:H7". Nature. 409 (6819): 529-33. Bibcode:2001Natur.409.. ...
"Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?" (PDF). FEMS ... "Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the ... "Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli ... The P fimbriae is considered to be one of the most important virulence factor in uropathogenic E. coli and plays an important ...
These pili are virulence factors involved in adhesion, especially important in uropathogenic Escherichia coli. The gene ... The fim switch in Escherichia coli is the mechanism by which the fim gene cluster, encoding Type I Pili, is transcriptionally ... Klemm, P (1986). "Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli ... and pH Growth Conditions Regulate fim Gene Transcription and Type 1 Pilus Expression in Uropathogenic Escherichia coli". ...
... the adhesin of uropathogenic Escherichia coli (UPEC). Work with E. coli stems from observations of human acquired immunity. ... August 1999). "X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli". Science. 285 ( ... "Distribution of drb genes coding for Dr binding adhesins among uropathogenic and fecal Escherichia coli isolates and ... "Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli". J ...
"The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine". Infection ... coli outbreak 2011 Germany E. coli O104:H4 outbreak Escherichia coli O104:H4 Escherichia coli O121 Food-induced purpura List of ... Escherichia coli O157:H7 is a serotype of the bacterial species Escherichia coli and is one of the Shiga-like toxin-producing ... Lim JY, Yoon J, Hovde CJ (January 2010). "A brief overview of Escherichia coli O157:H7 and its plasmid O157". Journal of ...
"The development and early clinical testing of the ExPEC4V conjugate vaccine against uropathogenic Escherichia coli". Clinical ... Uropathogenic E. coli from the gut is the cause of 80-85% of community-acquired urinary tract infections, with Staphylococcus ... Escherichia coli is the single most common microorganism, followed by Klebsiella and Proteus spp., to cause urinary tract ... The most common cause of infection is Escherichia coli, though other bacteria or fungi may sometimes be the cause. Risk factors ...
2008). "UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli". J Bacteriol. ...
"Suppression of type 1 pilus assembly in uropathogenic Escherichia coli by chemical inhibition of subunit polymerization". ...
Uropathogenic Escherichia coli (UPEC) is the major aetiological agent of Urinary Tract Infections (UTIs) and is often studied ... Pilicides inhibit the FGL chaperone/usher assisted biogenesis of thefimbrial polyadhesin from uropathogenic Escherichia coli. ... 2006) Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria.Proc Natl Acad Sci U S A 103: ...
"The RyfA small RNA regulates oxidative and osmotic stress responses and virulence in uropathogenic Escherichia coli". PLOS ... MicF in E. coli was found to regulate the expression of a key structural gene that makes up the outer membrane of the E. coli ... The small RNA ryfA has been found to affect the stress response of uropathogenic E.coli, under osmotic and oxidative stress. ... 5 prime ureB sRNA Aar small RNA, an sRNA produced by species of Acinetobacter Bacillus subtilis BSR sRNAs Escherichia coli sRNA ...
"Quantitative Analysis of Amyloid-Integrated Biofilms Formed by Uropathogenic Escherichia coli at the Air-Liquid Interface". ...
"The Repeat-In-Toxin Family Member TosA Mediates Adherence of Uropathogenic Escherichia coli and Survival during Bacteremia". ... In Escherichia coli, Pasteurella haemolytica, and Vibrio cholerae, TolC functions as the OMP in T1SS RTX toxin export. In each ... Enterohaemorrhagic Escherichia coli (EHEC) also produces an RTX toxin. EHEC haemolysin (EHEC-Hly) was discovered in the EHEC ... The prototypical RTX toxin, α-haemolysin (HlyA; TC# 1.C.11.1.3), is a common virulence factor in uropathogenic E. coli (UPEC), ...
... of a Uropathogenic Escherichia coli: An Approach to Inhibit Microbial Biofilms". Frontiers in Immunology. 8: 1552. doi:10.3389/ ... The team led by him collect Escherichia coli and Klebsiella pneumoniae strains from hospital and community-acquired infection ... Zuberi, Azna; Misba, Lama; Khan, Asad U (2017). "CRISPR Interference (CRISPRi) Inhibition of luxS Gene Expression in E. Coli: ...
Stapleton, A.; Nudelman, E.; Clausen, H.; Hakomori, S.; Stamm, W. E. (1992). "Binding of uropathogenic Escherichia coli R45 to ... phenotype is associated with an increased susceptibility to infections by Candida and uropathogenic Escherichia coli. In ...
Matin used bioreactors to generate simulated microgravity (SMG) on Earth, and showed that uropathogenic Escherichia coli (UPEC ... "Tetracycline Rapidly Reaches All the Constituent Cells of Uropathogenic Escherichia coli Biofilms". Antimicrobial Agents and ... Regulation of Escherichia coli starvation sigma factor (σs) by ClpXP protease. Journal of Bacteriology 178: 470-476. Schultz, J ... Reeve, C. A., Amy, P. S., & Matin, A. (1984). Role of protein synthesis in the survival of carbon-starved Escherichia coli K-12 ...
2001 Structural and sequence diversity of the pathogenicity island of uropathogenic Escherichia coli which encodes the USP ... mosomal regions coding for fimbriae and hemolysins occur in vivo and in vitro in various extraintestinal Escherichia coli iso- ... The P fimbriae island contains virulence factors such as haemolysin, pili, cytotoxic necrosing factor, and uropathogenic ...
She researched the genetic mechanism and control of host attachment by uropathogenic Escherichia coli as part of the Normark ... "The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation ... and functional analysis of the papC gene required for cell surface localization of Pap pili of uropathogenic Escherichia coli ... Tennent, J. M.; Lindberg, F.; Normark, S. (May 1990). "Integrity of Escherichia coli P pili during biogenesis: properties and ...
... including uropathogenic Escherichia coli, Helicobacter pylori, and Listeria monocytogenes. Gordon and his laboratory are ...
... mutants of a uropathogenic Escherichia coli O75:K5 strain". Infect. Immun. 67 (8): 3757-62. doi:10.1128/IAI.67.8.3757-3762.1999 ... Some examples are the K5 capsule and O75 O antigen found on the surface of Escherichia coli, and the exopolysaccharide capsules ... "Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract". Proc. Natl. Acad. Sci. U.S.A. 93 (18): ...
Buetow L, Flatau G, Chiu K, Boquet P, Ghosh P (July 2001). "Structure of the Rho-activating domain of Escherichia coli ... CNF1 is expressed in strains of E. coli causing uropathogenic and neonatal meningitis. CNF1 alters host cell actin cytoskeleton ... Cytotoxic necrotizing factor 1 (CNF1) is a toxin whose structure from Escherichia coli revealed a 4-layer alpha/beta/beta/alpha ... Wang, Ming-Hsien; Kim, Kwang (2013). "Cytotoxic Necrotizing Factor 1 Contributes to Escherichia coli Meningitis". Toxins. 5 (11 ...
... localisation and biofilm formation in clinically important species such as uropathogenic Escherichia coli and Pseudomonas ... 2011). "Urinary tract infections of Escherichia coli strains of chaperone-usher system". Polish Journal of Microbiology. 60 (4 ...
... J ... By comparing the growth patterns of prototypical enteropathogenic, uropathogenic, and nonpathogenic Escherichia coli strains ... Of the seven σ factors in Escherichia coli and related bacteria, σ54 exists in a class of its own. This study has uncovered ... Keywords: Escherichia coli; RNA polymerase; UPEC; microcolonies; sigma 54; sigma factors; transcription. ...
Methods: Here, we report an efficient gene editing strategy based on direct delivery of Cas9 and gRNA into Uropathogenic E. ... coli (UPEC) isolate. P-fimbriae plays major role in bacterial adherence to the uroepithelium through the Galα1-4Gal-binding ... particularly inEscherichia coli. Due to increased resistance, there is an exigency to develop novel therapeutic targets to ... Carbon Quantum Dots Conjugated CRISPR-cas9-gRNA Antimicrobials Against Antibiotic Resistant Uropathogenic Escherichia coli * ...
Case-Control Studies Child Dysentery Escherichia Coli Escherichia Coli Infections Escherichia Coli Proteins Humans Microbial ... "Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A" 13, no. 5 (2007). Wallace-Gadsden, Faith et al. " ... 2007). Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A. 13(5). Wallace-Gadsden, Faith et al. " ... "Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A" vol. 13, no. 5, 2007. Export RIS Citation ...
... Svensson, Lovisa University of ... 1. Nitric oxide and bacteria-host interactions in Escherichia coli urinary tract infection. Open this publication in new window ... Nitric oxide and bacteria-host interactions in Escherichia coli urinary tract infection. Svensson, Lovisa. University of Kalmar ...
Detection of blaTEM and blaCTX-M genes by multiplex polymerase chain reaction amongst uropathogenic Escherichia coli strains ... Detection of blaTEM and blaCTX-M genes by multiplex polymerase chain reaction amongst uropathogenic Escherichia coli strains ... Detection of blaTEM and blaCTX-M genes by multiplex polymerase chain reaction amongst uropathogenic Escherichia coli strains ... detection-of-blatem-and-blactx-m-genes-by-multiplex-polymerase-chain-reaction-amongst-uropathogenic-escherichia-coli-strains- ...
Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. * Nancy McNamara ... Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Periplasmic peptidyl prolyl cis-trans ... but SurA is required for pilus biogenesis in Escherichia coli. » ...
Uropathogenic Escherichia coli (UPEC) is responsible for the majority of urinary tract infections (UTI). To cause a UTI, UPEC ... Colorized scanning electron microscopy of an E. coli biofilm developing on a glass surface ...
Escherichia coli and Proteus mirabilis12,13,14,15,16,17 and can induce a state of iron limitation in uropathogenic E. coli21. ... Induction of a state of iron limitation in uropathogenic Escherichia coli CFT073 by cranberry-derived proanthocyanidins as ... Propolis potentiates the effect of cranberry (Vaccinium macrocarpon) against the virulence of uropathogenic Escherichia coli * ... Pectic Oligosaccharides from Cranberry Prevent Quiescence and Persistence in the Uropathogenic Escherichia coli CFT073 *Jiadong ...
Regulation of the pap operon in uropathogenic Escherichia coli is phase variable. This phase variation arises from competition ... Stochastic Modeling of the Phase-Variable pap Operon Regulation in Uropathogenic Escherichia coli ...
... ... Here we demonstrate the interconnected nature of the YpdAB and BtsRS TCSs in uropathogenic Escherichia coli (UPEC). ...
... coli strains, it is likely that stx1 and stx2 genes are also found in the Uropathogenic E. coli. Studies in different parts of ... Therefore, the present study was conducted to investigate the presence of verotoxin genes in Uropathogenic E. coli; 2)Methods: ... On the other hand, E. coli producing Shiga toxin (STEC), the so-called Verotoxinproducing E. coli (VTEC), has two stx1 and stx2 ... After diagnostic tests and differential biochemistry tests, 100 samples were confirmed as E. coli and the presence of stx2 and ...
Antibiofilm activity of kefir probiotic Lactobacilli against uropathogenic Escherichia coli.Sep 30, 2020. ... Protective properties of kefir on burn wounds of mice that were infected with S. aureus, P. auroginasa and E. coli.Sep 29, 2019 ...
Antibiotic resistant, Uropathogenic Escherichia coli Introduction Urinary tract infections (UTIs) are among the commonest human ... Mittal S, Sharma M, Chaudhary U (2015) Biofilm and multidrug resistance in uropathogenic Escherichia coli. Pathog Glob Health ... Karigoudar RM, Karigoudar MH, Wavare SM, Mangalgi SS (2019) Detection of biofilm among uropathogenic Escherichia coli and its ... Naziri Z, Kilegolan JA, Moezzi MS, Derakhshandeh A (2021) Biofilm formation by uropathogenic Escherichia coli: A complicating ...
Ribonuclease 7 Shields the Kidney and Bladder from Invasive Uropathogenic Escherichia coli Infection.. Eichler, Tad; Bender, ... as a human antimicrobial peptide that has bactericidal activity against uropathogenic Escherichia coli (UPEC). Functional ... Infecções por Escherichia coli/enzimologia Rim/enzimologia Ribonucleases/genética Bexiga Urinária/enzimologia Infecções ... Escherichia coli Uropatogênica Adolescente Animais Antibacterianos/farmacologia Peptídeos Catiônicos Antimicrobianos/genética ...
An Approach to Uropathogenic Escherichia Coli in Urinary Tract Infections by: K Prabhat Ranjan, et al. Published: (2010-07-01) ... The Gene Expression Profile of Uropathogenic Escherichia coli in Women with Uncomplicated Urinary Tract Infections Is ... DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli by: Michelle Madelung, et al. ... Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains by: Maryam Raeispour, et al. ...
We found 55 Escherichia coli and 19 Klebsiella pneumoniae strains confirmed uropathogenic following screening for the ... Pan-Resistome Characterization of Uropathogenic Escherichia coli and Klebsiella pneumoniae Strains Circulating in Uganda and ... Our findings illustrate the abundant acquired resistome and virulome repertoire in uropathogenic E. coli and K. pneumoniae, ... Pangenome analysis of each set revealed a total of 2862 and 3464 genes comprised the core genome of E. coli and K. pneumoniae ...
... coli K-12. Uropathogenic Escherichia coli (UPEC) AlignACE Matrices that search for additional binding sites in the E. coli ... Wikispecies has information related to Escherichia coli. Wikimedia Commons has media related to Escherichia coli. EcoCyc - ... coli helped produce E. coli O157:H7, the Shiga toxin-producing strain of E. coli. E. coli encompasses an enormous population of ... "Uropathogenic Escherichia coli: The Pre-Eminent Urinary Tract Infection Pathogen". Nova publishers. Archived from the original ...
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun. 2011 Feb. 79(2):628-35. [QxMD MEDLINE Link]. [Full ... Laboratory studies suggest that specific strains of E coli are specifically uropathogenic (ie, uropathogenic E coli [UPEC]). ... Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J. Biofilm formation in uropathogenic Escherichia coli strains: ... Escherichia coli infection is a common cause of acute bacterial prostatitis. However, these bacteria cannot be cultured in ...
"The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms". npj Biofilms and Microbiomes. 6 ... Escherichia coli[edit]. Escherichia coli biofilms are responsible for many intestinal infectious diseases.[116] The ... The insect antimicrobial peptide cecropin A can destroy planktonic and sessile biofilm-forming uropathogenic E. coli cells, ... Escherichia coli, or Pseudomonas aeruginosa).[87] Cyanobacteria also form biofilms in aquatic environments.[88] ...
Complete closed genome sequences of multidrug resistant uropathogenic Escherichia coli (Peer Reviewed Journal) (21-Aug-23) ...
Emody, L.; Kerenyi, M.; Nagy, G. Virulence factors of uropathogenic Escherichia coli. Int. J. Antimicrob. Agents 2003, 2, 29-33 ... Arisoy, M.; Aysev, D.; Ekim, M.; Ozel, D.; Kose, S.K.; Ozso, E.D.; Akar, N. Detection of virulence factors of Escherichia coli ... Uropathogenic E. coli (UPEC) possesses many redundant virulence factors that allow bacteria to resist and overcome various host ... Due to high incidence, the financial implications of UTIs are enormous [1]. Escherichia (E.) coli is the most frequent agent ( ...
OXA-48-Producing Uropathogenic Escherichia coli Sequence Type 127, the Netherlands, 2015-2022 M. Mulder et al. View Abstract. ... During 2015-2022, a genetic cluster of OXA-48-producing uropathogenic Escherichia coli sequence type 127 spread throughout the ... Shiga Toxin‒Producing Escherichia coli Diagnoses from Health Practitioners, Queensland, Australia A. C. Shrestha et al. ...
Sequencing of uropathogenic Escherichia coli strain UTI89 on multiple sequencing platforms. Sample: Ion Torrent reads of UTI89 ... SRX4225380: Whole genome sequencing (Ion Torrent) of Escherichia coli UTI89. 1 ION_TORRENT (Ion Torrent PGM) run: 776,426 spots ... Study: Escherichia coli UTI89 Raw sequence reads. PRJNA474982 • SRP150664 • All experiments • All runs ...
Selected virulence factors of uropathogenic Escherichia coli strains and clinical course of urinary tract infections in ... Selected virulence factors of uropathogenic Escherichia coli strains and clinical course of urinary tract infections in ... Enterohemorrhagic Escherichia coli O157 infection in children Wanda Bako, Anna Liberek, [...] Janina Raczkowska-Kozak, Irena ... Enterohemorrhagic Escherichia coli O157 infection in children Wanda Bako, Anna Liberek, Janina Raczkowska-Kozak, Irena ...
Ulett, G. C., Totsika, M., Schaale, K., Carey, A. J., Sweet, M. J., and Schembri, M. A. (2013). Uropathogenic Escherichia coli ... Wiles, T. J., Kulesus, R. R., and Mulvey, M. A. (2008). Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp ... Croxen, M. A., and Finlay, B. B. (2010). Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 8, 26-38 ... 57 Escherichia coli, 10 Proteus mirabilis and 1 Klebsiella pneumoniae). Epidemiological data related to age, years of evolution ...
Uropathogenic Escherichia coli suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect ... Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided ...
Characterizing Bladder Adaptive Immune Responses to Uropathogenic Escherichia coli Infections  Chan, Cheryl Yuen Yu (2012) ...
Uropathogenic Escherichia coli infection-induced epithelial trained immunity impacts urinary tract disease outcome. Russell SK ... Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Spaulding CN, Klein RD, Ruer S, Kau AL, ...
  • By comparing the growth patterns of prototypical enteropathogenic, uropathogenic, and nonpathogenic Escherichia coli strains devoid of σ 54 , we uncovered that the absence of σ 54 results in two differently sized colonies that appear at different times specifically in the uropathogenic E. coli (UPEC) strain. (nih.gov)
  • Here, we report an efficient gene editing strategy based on direct delivery of Cas9 and gRNA into Uropathogenic E. coli (UPEC) isolate. (microbiologyresearch.org)
  • Production of extended-spectrum β-lactamase (ESBL) is one of the most important resistance mechanisms that hamper the antimicrobial treatment of infections caused by uropathogenic Escherichia coli (UPEC). (innspub.net)
  • Uropathogenic Escherichia coli (UPEC) is responsible for the majority of urinary tract infections (UTI). (pasteur.fr)
  • Here we demonstrate the interconnected nature of the YpdAB and BtsRS TCSs in uropathogenic Escherichia coli (UPEC). (vanderbilt.edu)
  • 1) Background: Uropathogenic E. coli (UPEC) is responsible for 70-90% of urinary tract infections. (ac.ir)
  • Urinary tract infections (UTIs), mostly caused by uropathogenic E. coli (UPEC), are important human infections. (clinmedjournals.org)
  • Uropathogenic E. coli (UPEC) are endowed with several virulence associated factors (VFs) that enable the organism to attach, invade, and injure the host. (clinmedjournals.org)
  • We previously identified ribonuclease 7 ( RNase 7) as a human antimicrobial peptide that has bactericidal activity against uropathogenic Escherichia coli (UPEC). (bvsalud.org)
  • Urinary tracts infection (UTI) caused by uropathogenic Escherichia coli (UPEC) is a common infectious disease. (uitm.edu.my)
  • Molecular Characteristics of Extraintestinal Pathogenic E. coli (ExPEC), Uropathogenic E. coli (UPEC), and Multidrug Resistant E. coli Isolated from Healthy Dogs in Spain. (preprints.org)
  • Under one-health perspective and the worldwide antimicrobial resistance concern, we investigate extraintestinal pathogenic Escherichia coli (ExPEC), uropathogenic E. coli (UPEC), and multidrug resistant (MDR) E. coli from 197 isolates recovered from healthy dogs in Spain between 2013 and 2017. (preprints.org)
  • All these findings suggest that dogs are reservoirs of ExPEC, UPEC and MDR E. coli isolates with zoonotic potential. (preprints.org)
  • Uropathogenic E coli (UPEC) has the ability to colonize the uroepithelium by means of surface fimbriae. (medscape.com)
  • Among the common uropathogens associated to UTIs development, UroPathogenic Escherichia coli (UPEC) is the primary cause. (scienceopen.com)
  • Cranberry-based supplements and/or juice are a welcome alternative for patients and health care providers alike, especially with growing concerns of antibiotic resistance against uropathogenic Escherichia coli strains (UPEC). (naturalmedicinejournal.com)
  • The increasing prevalence of antibiotic-resistant uropathogenic E. coli (UPEC) together with the recognition of UPEC as intracellular bacteria confront our current treatment regimens of urinary tract infections. (oru.se)
  • The human urinary tract is one of the most common sites of bacterial infection and most of them are caused by uropathogenic Escherichia coli (UPEC). (esrf.fr)
  • Uropathogenic Escherichia coli (UPEC) attach specifically to human bladder cells using surface structures known as type 1 pili. (esrf.fr)
  • Multidrug-resistant, chuA -positive E. coli H18 strains and R-FLIC2 (5-CTAACCCTGCAGCAGAGACA-3), are also frequently recovered from patients with urinary we obtained an internal fl iC amplicon from 105 (80.1%) tract infection. (cdc.gov)
  • A total of 100 E. coli strains, isolated from hospitalized patients were phenotypically screened for ESBL production using drug-inhibitor combination disks, namely, ceftazidime-clavulanate (30+10μg) and cefotaxime-clavulanate (30+10μg) following CLSI guidelines. (innspub.net)
  • Since these genes are plasmidal and can be transmitted between E. coli strains, it is likely that stx1 and stx2 genes are also found in the Uropathogenic E. coli. (ac.ir)
  • Also, the incidence of urinary tract infections caused by Verotoxigenic E. coli strains is increasing. (ac.ir)
  • Microbial Susceptibility, Virulence Factors, and plasmid profile of uropathogenic Escherichia coli strains Isolated from children in Jahrom, Iran. (ac.ir)
  • Detection of Shiga Toxin-Producing Strains of Escherichia coli (O157: H7) isolated from specimens of urinary and stool by Multiplex-PCR method. (ac.ir)
  • We found 55 Escherichia coli and 19 Klebsiella pneumoniae strains confirmed uropathogenic following screening for the prevalence of UTI virulence genes including fimH, iutA, feoA/B/C, mrkD, and foc. (uncst.go.ug)
  • We identified 18 different sequence types in E. coli population while all K. pneumoniae strains belong to ST11. (uncst.go.ug)
  • Overall, 93% are multi-drug resistant in the E. coli collection while 100% of the K. pneumoniae strains contained genes that are associated with resistance to three or more antibiotic classes. (uncst.go.ug)
  • Hemolytic-uremic syndrome (HUS) is a potentially devastating consequence of enteric infection with specific E coli strains. (medscape.com)
  • 1] "Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. (tcdb.org)
  • Yet, most of what we know about E. coli stems from the investigation of laboratory strains, which fail to capture the ecology and evolution of this key organism "in the wild" ( Hobman, Penn & Pallen, 2007 ). (peerj.com)
  • Extended-spectrum β-Lactamases in ceftazidime resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals. (innspub.net)
  • However, despite this staggering statistic, very few studies have investigated the relationship between biofilm production and host factors such age group and hospitalization status, and non-host factors, including recurrence of UTI, phylogenetic group distribution, and antibiotic susceptibility, among urinary E. coli isolates from reproductive age women. (clinmedjournals.org)
  • In contrast to the essential and beneficial role of most E coli isolates in the human intestine, pathogenic E coli are responsible for a broad spectrum of human disease. (medscape.com)
  • We isolated and whole-genome sequenced up to five colonies of faecal E. coli from 66 asymptomatic children aged three-to-five years in rural Gambia (n = 88 isolates from 21 positive stools). (peerj.com)
  • Several isolates encode putative virulence factors commonly found in Enteropathogenic and Enteroaggregative E. coli, and 53% of the isolates encode resistance to three or more classes of antimicrobials. (peerj.com)
  • ABSTRACT We investigated antimicrobial resistance patterns and plasmid profiles of uropathogenic Escher- ichia coli isolates from inpatients and outpatients at Jordan University Hospital in 2000 and 2001. (who.int)
  • E. coli accounted for 32.4% and 37.4% of all isolates respectively. (who.int)
  • A large, transferable R-plasmid of 28 kb was found in most E. coli isolates (67%) that were resistant to at least ampicillin, cotrimoxazole and tetracycline. (who.int)
  • Eight to 10 colonies of tance to fluoroquinolones among uropatho- each pure culture of E. coli were taken and genic E. coli isolates [ 1-14 ]. (who.int)
  • We included 53 multidrug-resistant E. munity and hospitalized patients at a major coli isolates that were susceptible to nalid- teaching hospital in Jordan. (who.int)
  • Uropathogenic Escherichia coli strain CFT073 disrupts NLRP3 inflammasome activation. (umm.de)
  • Although clinical microbiology typically relies on single-colony picks (which has the potential to underestimate species diversity and transmission events), within-host diversity of E. coli in the gut is crucial to our understanding of inter-strain competition and co-operation and also for accurate diagnosis and epidemiological analyses. (peerj.com)
  • Pregnant women are at a higher risk of colonization with the K1 capsular antigen strain of E coli . (medscape.com)
  • to which uropathogenic E. coli clonal group A belongs. (cdc.gov)
  • Title : Enteroaggregative Escherichia coli Related to Uropathogenic Clonal Group A Personal Author(s) : Wallace-Gadsden, Faith;Johnson, James R.;Wain, John;Okeke, Iruka N. (cdc.gov)
  • The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. (innspub.net)
  • Our findings illustrate the abundant acquired resistome and virulome repertoire in uropathogenic E. coli and K. pneumoniae, which are mainly disseminated via clonal and horizontal transfer, circulating in the East African region. (uncst.go.ug)
  • In most UTI cases, E. coli is the causative pathogen, with over 80-90% of uncomplicated UTIs caused by this organism [ 3 ]. (clinmedjournals.org)
  • Escherichia coli is a versatile organism and very diverse. (intechopen.com)
  • E. coli has also been used as a model organism for most bacteria except a few. (intechopen.com)
  • Escherichia coli was the infecting organism in 83% of cases. (who.int)
  • Enteropathogenic E coli (EPEC) is a cause of childhood diarrhea. (medscape.com)
  • On the other hand, E. coli producing Shiga toxin (STEC), the so-called Verotoxinproducing E. coli (VTEC), has two stx1 and stx2 genes (Producing Stx1 and Stx2 toxins). (ac.ir)
  • and 4) Conclusions: It seems that the frequency of verotoxin genes in E. coli causing urinary tract infections in Kermanshah is more than the other parts of Iran. (ac.ir)
  • Prevalence of Shiga toxin genes and intimin genes in uropathogenic Escherichia coli. (ac.ir)
  • Prevalence of Shiga toxin and Intimate genes in Shiga toxin-producing Escherichia coli isolated from urine samples in Lorestan, Iran. (ac.ir)
  • 2019). Frequency of sfa, cnf-1 and hly genes in Escherichia coli isolated in urine of patients with urinary tract infections. (ac.ir)
  • Prevalence of Shiga Toxin-Producing Genes in Escherichia Coli Isolated From Patients with Urinary Tract Infections in Khorramabad. (ac.ir)
  • Detection of STX1, STX2, LT and ST toxin genes, and O157 and H7 antigen genes among uropathogenic Escherichia coli isolated from Iran. (ac.ir)
  • Pangenome analysis of each set revealed a total of 2862 and 3464 genes comprised the core genome of E. coli and K. pneumoniae population, respectively. (uncst.go.ug)
  • Some of the key genes involved in filamentation in E. coli include sulA, minCD and damX. (wikipedia.org)
  • Thus, resident E. coli in these children may constitute reservoirs of virulence- and resistance-associated genes. (peerj.com)
  • Enteroaggregative E coli (EAggEC) is primarily associated with persistent diarrhea in children in developing countries, and enteroadherent E coli (EAEC) is a cause of childhood diarrhea and traveler's diarrhea in Mexico and North Africa. (medscape.com)
  • Superficial infection with E. coli was associated with a reduced duration of hospital stay by −2.46 days and a reduced odds ratio of infectious diseases as main diagnosis of 0.04. (scienceopen.com)
  • Transcriptional alterations in bladder epithelial cells in response to infection with different morphological states of uropathogenic Escherichia coli. (oru.se)
  • Little is known about the genomic diversity of Escherichia coli in healthy children from sub-Saharan Africa, even though this is pertinent to understanding bacterial evolution and ecology and their role in infection. (peerj.com)
  • Escherichia coli is one of the most frequent causes of many common bacterial infections, including cholecystitis, bacteremia, cholangitis, urinary tract infection (UTI), and traveler's diarrhea, and other clinical infections such as neonatal meningitis and pneumonia. (medscape.com)
  • E coli bacteremia precedes pneumonia and is usually due to another focus of E coli infection in the urinary or GI tract. (medscape.com)
  • Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. (kegg.jp)
  • 2012). Study Prevalence of Verotoxigenic E.coli Isolated from Urinary Tract Infections (UTIs) in an Iranian Children Hospital. (ac.ir)
  • E coli is also a commonly identified cause of urinary tract infections (UTIs) , as well as neonatal sepsis and meningitis. (medscape.com)
  • First described in 1885, E coli has become recognized as both a harmless commensal and a versatile pathogen. (medscape.com)
  • Analysis of the variability of S fimbriae expression in an Escherichia coli pathogen. (uni-wuerzburg.de)
  • Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. (nature.com)
  • Escherichia coli could associate a specifi c H antigen with 10 of these RFLP patterns. (cdc.gov)
  • The characteristic serotype of this pathogenic E coli displays the K1 antigen, which is responsible for 40% of the cases of bacteremia and 80% of the cases of meningitis caused by E coli . (medscape.com)
  • 40% glycerol and then stored at -20 °C for terns and plasmid profiles of uropathogenic further investigation. (who.int)
  • Further, all of the mcr-positive genomes were identified as Escherichia coli and all contained a IncX4 plasmid replicon. (cdc.gov)
  • Of the seven σ factors in Escherichia coli and related bacteria, σ 54 exists in a class of its own. (nih.gov)
  • Filamentation is the anomalous growth of certain bacteria, such as Escherichia coli, in which cells continue to elongate but do not divide (no septa formation). (wikipedia.org)
  • It was demonstrated by itrtmunofluorescence microscopy that in noimal (wild-type) and hyperS- fimbriated E. coli populaiions non-fimbriated cells also · exist, and that the percentage of Sfinibrlated and non-fimbriated bacteria was roughly identica1 in either population. (uni-wuerzburg.de)
  • Characterization of different strategies used by uropathogenic bacteria to weaken or modulate the host immune response is one research area of major interest. (oru.se)
  • Escherichia coli, a facultatively anaerobic gram-negative bacillus, is a major component of the normal intestinal flora and is ubiquitous in the human environment. (medscape.com)
  • E coli is facultatively anaerobic with a type of metabolism that is both fermentative and respiratory. (medscape.com)
  • Hence, we conclude that CQD-CRISPR-Cas9-gRNA could be a novel therapeutic strategy for the eradication or treatment of antibiotic resistant pathogenic E. coli -based pathologies. (microbiologyresearch.org)
  • His main research interest focuses on understanding the molecular mechanisms of bacterial pathogenesis with a specific focus on uropathogenic Escherichia coli. (dillard.edu)
  • UTI, although treatable, is now becoming increasingly tough to control because of rampant antimicrobial resistance in the Enterobacteriaceae family, particularly inEscherichia coli. (microbiologyresearch.org)
  • Rapid detection of cefotaxime-resistant Escherichia coli by LC-MS.Burrer A, Findeisen P, Jäger E, Ghebremedhin B, Grundt A, Ahmad-Nejad P, Miethke T, Neumaier M. Int J Med Microbiol. (umm.de)
  • Enterohemorrhagic E coli (EHEC) causes hemorrhagic colitis or hemolytic-uremic syndrome (HUS). (medscape.com)
  • Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. (wustl.edu)
  • Antibiotic resistance in uropathogenic Escherichia coli isolated from urinary tract infections out-patients in Kermanshah. (ac.ir)
  • Also, this study adds significantly to the number of commensal E. coli genomes, a group that has been traditionally underrepresented in the sequencing of this species. (peerj.com)
  • In addition, S fimbriae have been associated with many of the E coli of patients with CNS infections. (medscape.com)
  • Methods: Over a 5-year interval, patients in whom either E. coli or S. aureus was detected in superficial or primary sterile compartments were assessed for the primary endpoint death during hospital stay and the secondary endpoints duration of hospital stay and infectious disease as the main diagnosis. (scienceopen.com)
  • The hospital stay of patients with E. coli was increased due to third-generation cephalosporin and ciprofloxacin resistance, and in the case of patients with S. aureus due to tetracycline and fusidic acid resistance. (scienceopen.com)
  • However, E coli pneumonia may also be community-acquired in patients who have underlying disease such as diabetes mellitus, alcoholism, chronic obstructive pulmonary disease, and E coli UTI. (medscape.com)
  • Enteroinvasive E coli (EIEC) causes a Shigella -like dysentery. (medscape.com)
  • The role of caspase-1, caspase-4 and NLRP3 in regulating the host cell response evoked by uropathogenic Escherichia coli. (oru.se)
  • Systemic infections caused by E coli are frequently seen in neonates either by means of vertical or horizontal transmission. (medscape.com)
  • E coli O157:H7 is the most virulent of the EHEC. (medscape.com)
  • Enterotoxigenic E coli (ETEC) is a cause of traveler's diarrhea. (medscape.com)
  • EHEC, also known as Shiga-toxin producing E coli (STEC), induces an attaching and effacing (AE) lesion in the large bowel. (medscape.com)
  • Conclusions: Reduced disease severity of superficial infections due to both E. coli and S. aureus and resistance-driven prolonged stays in hospital were confirmed, while other outcome parameters were comparable. (scienceopen.com)
  • The book has been divided into four main sections representing the different facets of E. coli applications, which include disease, biotechnology, environmental engineering and innovative approaches to detection, and lastly its physiology and cell biology. (intechopen.com)
  • The vast majority of neonatal meningitis cases are caused by E coli and group B streptococcal infections (28.5% and 34.1% overall, respectively). (medscape.com)
  • In adults, E coli meningitis is rare but may occur following neurosurgical trauma or procedures or complicating Strongyloides stercoralis hyperinfection involving the CNS. (medscape.com)
  • A Comparative Analysis of the Mechanism of Toll-Like Receptor-Disruption by TIR-Containing Protein C from Uropathogenic Escherichia coli. (umm.de)
  • These were spread over 37 seven-allele sequence types and the E. coli phylogroups A, B1, B2, C, D, E, F and Escherichia cryptic clade I. Immigration events accounted for three-quarters of the diversity within our study population, while one-quarter of variants appeared to have arisen from within-host evolution. (peerj.com)
  • Escherichia organisms are gram-negative bacilli that exist singly or in pairs. (medscape.com)
  • When bile flow is obstructed, colonic organisms, including E coli, colonize the jejunum and duodenum. (medscape.com)
  • The genus Escherichia is named after Theodor Escherich, who isolated the type species of the genus. (medscape.com)

No images available that match "uropathogenic escherichia coli"